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ABSTRACT OF THE DISSERTATION 
 
 The immune system must be able to fight potentially pathogenic microbial 
invaders without mounting an attack on its own tissues, food antigens, and harmless or 
beneficial commensal species. Despite the elimination of many self-reactive T cells in the 
thymus, some T cells with the ability to recognize self and potentially cause autoimmune 
disease are present in the periphery. The population of CD4+ regulatory T cells (Treg) 
expressing the transcription factor Foxp3 are required to actively maintain homeostasis of 
the immune system, but it is uncertain whether their function is antigen-specific. These 
studies address the repertoire of the variable T cell receptor expressed on each T cell, in 
an attempt to understand the role of specificity in the maintenance of tolerance. By 
sequencing of the TCRα chain on cells expressing a fixed TCRβ chain, we are able to 
compare the repertoire of TCRs on T cells from different populations. 
 These studies revealed that Treg use a repertoire of TCRs distinct from that of the 
CD4+CD44hi activated/memory or CD44lo naïve T cell subsets, and that it varies 
considerably depending upon the location of the cells. This data suggests that Treg home 
to and/or develop in areas in which they recognize antigen, presumably self antigens on 
the tissues which they protect. Most Treg develop their regulatory phenotype in the 
thymus; however, it is known that mature T cells can develop into Treg outside of the 
thymus, a process termed peripheral conversion. While we see evidence of a very small 
amount of contribution by peripheral conversion to the Treg repertoire of the spleen and 
lymph nodes, it has been proposed that the gut immune system is a major site of 
conversion. Therefore we studied the TCR repertoire of the colon, and indeed find that 
-x- 
the colonic Treg TCRs are very unique, and many of them recognize commensal bacterial 
antigens. We further show that thymocytes expressing these TCRs do not upregulate 
Foxp3 expression in the thymus, and for two of these TCRs, we show that Foxp3 
expression depends upon the composition of the intestinal microbiota. Therefore, our data 
supports a model in which Foxp3+ regulatory cells show antigen specificity for the tissues 
they protect, and in some cases develop in situ, allowing for tolerance to antigens that are 
not thymically presented. 
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CHAPTER ONE: INTRODUCTION 
 
CD4+ Foxp3+ Regulatory T Cells Maintain Immune Homeostasis  
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The need for T cell regulation 
 An essential feature of the adaptive immune system is the potential of T cells to 
recognize virtually any antigen. While this allows for the development of an immune 
response to a wide and constantly changing range of pathogens, it leaves open the 
possibility of T cells reactive to antigens derived from the self, as well as non-harmful 
foreign antigens derived from food, non-pathogenic, and beneficial commensal 
organisms. Therefore, there must exist mechanisms by which an immune response to 
these antigens is prevented, while still allowing for a response to potentially harmful 
organisms; the ability to discern self from non-self. 
 Central tolerance is the first line of defense against self-reactivity. Developing T 
cells in the thymus express a unique T cell receptor whose amino acid sequence is the 
product of gene segment rearrangement as well as random nucleotide addition and 
subtraction. The newly created receptor expressed by the developing T cell is then tested 
for the ability to recognize self-peptides presented by a major histocompatility complex 
(MHC).  Those T cells expressing a receptor unable to productively interact with 
available pepetide and MHC complexes (pMHC) do not survive, ensuring that only 
potentially useful T cells are contributed to the mature T cell pool. However, those T 
cells whose TCR reacts too strongly to these complexes are eliminated, in a process 
coined negative selection.  This ensures that most T cells released from the thymus do not 
react strongly to self antigens. 
 In spite of this process, however, there are T cells in the periphery capable of 
recognizing self-antigens and contributing to the development of autoimmune diseases 
[1]. This is attributed to the limitations of thymic negative selection; it is impossible for a 
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developing T cell to encounter every potential self-peptide/MHC complex that it might 
later encounter in the body, and not all self peptides are present in the thymus.  Therefore, 
other mechanisms are required to keep these potentially self-reactive T cells in check.  
These self-reactive T cells can be rendered unresponsive, a state termed anergic, in the 
periphery or may be sequestered from their cognate antigen and therefore remain ignorant 
[1].  
 In addition to these mechanisms, the existence of a “dominant” form of regulation 
mediated by a population of dedicated regulatory cells was proposed in the early 1970s 
[2, 3].  Several groups observed that T cells could not only augment but also dampen 
immune responses, and it was believed that this regulation was mediated by a unique 
population of T cells coined “suppressor T cells”. These cells gained quick acceptance 
and a flurry of reports on the nature of these cells and their functions were published in 
the 1970’s and early 1980’s. However, the development of new molecular biology 
techniques in the 1980’s began to cast doubt on the findings of these reports, particularly 
as some current beliefs about the structure of the MHC locus were proved to be incorrect 
[4].  Consequently, the field of “suppressor” T cells lost momentum and the support of 
most immunologists. However, studies in the 1990’s again began to report about a subset 
of T cells with suppressive capabilities, and to avoid the stigma of the earlier studies 
these were eventually coined “regulatory” T cells [2, 3]. It is now thought that these cells 
are one in the same with the suppressor cells of the 1970s, but improvements in 
technology that allow for better characterization of these cells have led to their wide 
acceptance, and much has been discovered about their nature. 
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Foxp3+ CD4+ regulatory T cells 
 Attempts to identify the population of regulatory T cells grew out of studies of the 
autoimmunity induced upon the transfer of populations of T cells into lymphopenic SCID 
or nude mice. Experiments reported in 1985 by Sakaguchi et. al. showed that the 
CD5hiCD4+ T cells contained the ability to prevent autoimmunity [5], and in 1990 it was 
shown that CD45RClo CD4+ T cells prevented disease in athymic rats [6]. Other studies 
identified this population as RT6.1+ T cells [7] or CD45RBlowCD4+ T cells [8, 9] in mice. 
Then, in 1995, CD25 (IL-2 receptor α-chain) was identified as a marker for a subset of 
CD4+ T cells contained in the CD5hi and CD45RBlo fraction, and depletion of the CD25-
expressing cells from a splenic cell suspension before transfer into a nude mouse 
produced a high incidence and wide range of autoimmune diseases in these recipient 
mice [10].  Purified CD25+ CD4+ T cells were subsequently shown to be capable of 
suppressing autoimmunity and effector T cell responses in a wide variety of systems. 
 While CD25 proved to be a good marker for regulatory T cells and its discovery 
pushed the field of regulatory T cells forward, its expression is not limited to this cell 
population alone, as it is transiently upregulated on all T cells upon activation. In 
addition, these cells were found to express high levels of other molecules previously 
identified as markers of T cell activation, such as the glucocorticoid induced TNF 
receptor (GITR) [11, 12], and cytotoxic T-lymphocyte-associated gene 4 (CTLA-4) [13, 
14]. Therefore, the search for a more specific indicator of the regulatory T cell lineage 
continued. In 2001, the transcription factor Foxp3 was identified as the defective gene in 
the scurfy mouse, a spontaneous mutant mouse known to develop severe autoimmunity as 
a result of an X-linked mutation [15]. Two years later, Foxp3 was found to be expressed 
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exclusively in the CD25+CD4+ regulatory T cell subset, and became the first, and to date 
only, gene known to be exclusively expressed in these cells [16-18]. Identification of 
Foxp3 as a definitive marker of regulatory T cells greatly facilitated the further study of 
this population, particularly once identification of these cells was simplified by the 
engineering of mice co-expressing Foxp3 with a fluorescent protein or a fusion of Foxp3 
with green fluorescent protein (GFP) [19-21]. 
  
The “Natural” Regulatory T Cell 
 It is now known that there are several types of lymphocytes possessing regulatory 
activity [22]. CD4+ regulatory T cells are often designated as “natural” Treg if they 
express Foxp3 and develop in thymus, and “induced” Treg if they are Foxp3– and are 
thought to differentiate in the periphery. Among these “induced” regulatory cells, there 
are several subtypes, based upon their ability to produce inhibitory cytokines. T cells that 
are induced in the gut after low doses of orally-administered antigen and produce TGFβ 
are termed “Th3” cells [23], while cells that produce large amounts of IL-10 are called 
“Tr1” cells [24]. Tr1 cells were first described after culture of T cells with antigen in the 
presence of IL-10, but have since been described as prevalent in the gut, particularly the 
small intestine [25], and also produce TGFβ, calling into question the distinction of their 
role from that of Th3 cells.  
 In addition to traditional CD4+ regulatory T cells, regulatory activity has been 
ascribed to other subsets of T cells, such as certain subsets of CD8+ cells (CD8αβ or 
CD8αα), γδ T cells, invariant natural killer T (iNKT) cells, and mucosal associated 
invariant T (MAIT) cells. Most of these have been described as playing a role in gut 
-6- 
tolerance [26].  Although poorly understood, these cells generally express an TCR 
displaying limited or no variation and recognize non-classical MHC molecules. Their 
mechanisms of regulation may involve interaction with the epithelial cell barrier or 
cytotoxic effects on antigen presenting cells. 
 
The importance of Foxp3+ Treg in tolerance 
 While regulatory cells that do not express Foxp3 have been shown to be involved 
in the regulation of effector T cell responses, particularly at mucosal sites such as the gut, 
it has been shown that they are not sufficient to maintain tolerance in the absence of 
Foxp3+ Treg. The scurfy mouse was first described as the result of a naturally-arising X-
linked mutation in a strain of mice in the 1950s. This mouse exhibited spontaneous, 
severe autoimmunity and inflammation which resulted in the death of the animals by 
about four weeks of age, and resembled the human disease immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome [15, 27]. The CD4+ T cells 
from these mice were capable of mediating disease upon transfer into lymphopenic SCID 
or nude mice, much like CD4+CD25– cells, and were hyperproliferative in vitro [28]. It 
was soon discovered that the mutant protein involved was the transcription factor Foxp3, 
resulting in the absence of Treg. Mutations in the human equivalent of this transcription 
factor are also responsible for reduced or absent Treg function in the human IPEX 
syndrome [29]. Therefore, in both mice and humans, Foxp3+ Treg are absolutely essential 
for the prevention of widespread autoimmunity.  The need for the continual presence of 
these cells in order to restrain self-reactive T cells was further confirmed by the creation 
of a mouse that expressed the human diphtheria toxin (DT) receptor on cells expressing 
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Foxp3, allowing for the deletion of these cells upon administration of DT. At any age, the 
administration of DT caused a rapid induction of rampant autoimmune syndromes, 
resulting in the death of the animals within 2-3 weeks [30].  
 
Thymic development of Foxp3+ Treg 
 As mentioned above, one criteria for the definition of a “natural” Treg is that they 
develop this phenotype during thymic development. The first clue that Treg indeed 
develop in the thymus was the model of autoimmunity induced upon thymectomy of 
mice at neonatal day 3 [31].  It was later confirmed that Treg are slightly delayed in their 
initial release from the thymus as compared to naïve, non-Treg cells, leaving these mice 
relatively deficient in Treg and resulting in disease [32]. A comparison of the repertoires 
of T cell receptor (TCR) sequences found on thymic CD4+Foxp3+ T cells and those found 
in the periphery (spleen and lymph nodes) showed a high similarity between these 
populations, suggesting that most or all Treg originate in the thymus [33-35]. 
 During T cell development in the thymus, TCRs, which are the product of 
randomly rearranged gene segments, interact with self-peptides presented by major 
histocompatibility (MHC) molecules expressed on thymic stromal cell or thymic 
dendritic cells (DC). If the TCR is unable to interact productively with the MHC, the 
developing T cell dies; as long as the interaction is above a certain threshold the cell 
receives a survival signal, or is “positively selected”. This ensures that only T cells 
capable of productive interactions with the MHC molecules enter the T cell pool. 
However, if the TCR recognizes the self-peptide/MHC complexes too strongly it receives 
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a death signal, or is “negatively selected”, to prevent this potentially self-reactive T cell 
from being released from the thymus and possibly causing disease.  
 Regulatory T cells are thought to be selected in the thymus based upon an affinity 
to self-peptide/MHC complexes that lies somewhere just below the threshold of negative 
selection, but higher than most non-regulatory T cells. The theory that a developing Treg 
must recognize its cognate peptide/MHC complex is supported by studies showing the 
increased Treg selection in TCR transgenic mice after expression of the antigen 
recognized by this TCR in the thymus of the mice [36]. An increased prevalence of self-
reactive TCRs among thymic Treg TCRs has been demonstrated by the transfer of T cells 
expressing Treg TCRs vs. non-Treg TCRs into lymphopenic hosts [37].  In these 
experiments, those T cells expressing Treg TCRs more often proliferated in response to 
unknown self-antigens encountered in the host animal. It is assumed that recognition of 
self-antigens by thymically derived Treg protects the tissues expressing those antigens 
from autoimmune attack. 
 
Peripheral development of Foxp3+ Treg 
 Although it seems most natural Treg found in the periphery of the mouse were 
selected into this lineage within the thymus, it has become clear that in certain situations 
Foxp3– cells can develop into Foxp3+ T cells which are phenotypically indistinguishable 
from thymically derived Treg. This process has been coined peripheral “conversion” of 
non-Treg into Treg. The circumstances under which it has been reported in vivo are 
mostly those of antigen presentation under suboptimal, or “tolerizing” conditions. These 
include the oral, intravenous, or prolonged subcutaneous administration of cognate 
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peptide in the absence of adjuvant [38, 39]; transplantation tolerance under the cover of 
blocking antibodies; direct delivery of antigen to DEC-205+ DCs (using a DEC-205 
antibody-antigen fusion)[40]; and the transfer of TCR transgenic (Tg) T cells into a 
recipient that expresses the cognate antigen [41]. In addition, the transfer of CD4+CD25– 
T cells into either a lymphopenic [42] or a non-lymphopenic [43] host will induce the 
development of T cell population stably expressing CD25.  
 While these experiments have demonstrated that non-regulatory cells have the 
ability to become Foxp3+ regulatory cells outside of the thymus, it remains unknown how 
prevalent this is under steady-state conditions in a normal individual. A few studies have 
attempted to address this.  The aforementioned transfer of CD4+CD25– T cells into a 
wild-type congenically marked host reported about 5-12% of transferred cells became 
CD25+ by six weeks post transfer [43]. The resulting cells were capable of inhibiting 
proliferation of effector cells in an in vitro proliferation assay. However, the use of CD25 
as the sole marker for Treg makes it likely that these results could over-estimate the 
amount of conversion in the system. Studies looking at the TCR repertoires of Foxp3+ 
and Foxp3– CD4 single-positive (SP) thymocytes versus peripheral Treg and non-Treg 
populations showed little evidence of conversion [34].  Additionally, an attempt to track 
the phenotype of TCR transgenic T cells specific for a pancreatic antigen which also 
express a secondary TCRα chain did not reveal that TCRα chains seen on the Foxp3– 
population in the thymus became part of the Foxp3+ population after exposure to the 
pancreatic antigen in the periphery[35]. 
 While current data is inconsistent about the contribution of peripheral conversion 
to the normal Treg repertoire, it is easy to imagine a role for conversion in particular 
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situations of novel antigen encounter. The peripheral development of regulatory T cells 
could potentially fill the role of mediating tolerance to food antigen, commensal 
microbiota, and any other self or harmless foreign antigen which would not be found in 
the thymus. Indeed, a study of oral tolerance in which Foxp3– OVA-specific TCR 
transgenic T cells (expressing the Foxp3gfp fusion protein) were transferred into a 
sublethally irradiated host subsequently fed OVA protein showed the induction of Foxp3 
expression on donor T cells in the small intestine lamina propria (LP) and mesenteric 
LNs [44]. This supports a role for peripheral conversion in the maintenance of tolerance 
to non-thymic antigens at mucosal sites such as the gut. 
 It has also been postulated that Treg recognizing foreign antigens routinely 
develop from activated effector cells during an immune response, in order to dampen 
down and prevent the response from getting out of control, and as source of 
replenishment for the Treg pool [45]. A role for Treg in balancing a potentially 
overzealous immune response has been shown in many types of infections, although the 
character and source of the Treg involved is unknown [46]. Treg accumulated at the site 
of infection have been shown to be specific for microbial antigens in Leishmania major 
infection of mice [47], although it is unknown what the source of these Treg is. After 
adoptive transfer of TCR transgenic T cells specific for a particular peptide/MHC 
(pMHC), intradermal immunization of a protein containing the peptide was shown to 
cause the accumulation of donor-derived TCR transgenic T cells of both Treg and IFNγ-
producing effector cell phenotypes, both of which were shown to recognize the cognate 
peptide/MHC complex by tetramer staining [48]. However, the use of incomplete 
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Freund’s adjuvant (IFA) in this study calls into question the relevance of this model to a 
microbial infection in which antigen would be presented in the context of TLR ligands. 
 
Mechanisms of suppression by Treg 
 Several mechanisms by which Treg may suppress immune responses have been 
reported [49, 50]. These can be divided according to whether the suppressive effect is 
directly on the effector T cells (Teff) in a contact dependent or independent way, or 
indirect via an alteration of the antigen presenting cells (APC). There seems to be no 
single, definitive mechanism by which Treg can suppress; it seems, instead, that they rely 
on a broad combination of actions whose role and importance vary according to the 
situation. 
 In in vitro suppression assays, contact between the Treg and the Teff cells appears 
to be required, as separation by a permeable membrane abrogates the suppressive effect 
[51]. In these studies, the presence of APC in the culture was not required. Contact-
mediated effects may involve the delivery of cytoplasmic cAMP from the Treg to the 
Teff by contact via gap junctions [52], or granzyme B-dependent killing [53]. However, 
this need for direct contact is not supported by in vitro and in vivo imaging studies in 
which the Treg and Teff cells are not shown to interact stably [54]. A recent report argues 
that the contact with the target T cell may actually provide the Treg with additional 
suppressive capabilities, such as the ability to secrete cytokines, and after this initial 
contact it may suppress in a contact-independent manner [55]. 
 Another mechanism by which Treg could suppress is by the production of 
inhibitory cytokines. While the blockade of the inhibitory cytokines IL-10 and TGFβ was 
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not reported to affect suppressive function in vitro [51], a role for these cytokines has 
been reported in several in vivo systems. The suppressive ability of Treg in a model of 
airway hyper-reactivity, as well as in various infections, depended upon IL-10, but in 
these cases the Treg themselves were not the source of the IL-10 [56-58]. However, in 
models of IBD, IL-10 production by the Treg themselves is absolutely essential for 
disease prevention. In addition, TGF-β also appears to be required for prevention of IBD, 
as Teff lacking the TGF-β receptor are refractory to Treg-mediated suppression in models 
of IBD [59, 60]. 
 Another, more recently discovered Treg-produced inhibitory cytokine is IL-35 
[61]. It is preferentially expressed by Treg, and its production is upregulated when they 
are actively suppressing. Treg deficient in either protein that makes up this heterodimeric 
cytokine show reduced regulatory activity in vitro, and are unable to control homeostatic 
proliferation or IBD in vivo. In addition, ectopic expression of this cytokine by naïve T 
cells caused them to gain regulatory activity, and addition of recombinant IL-35 can 
suppress proliferation in vitro. Although not much is known about this cytokine, it is 
likely to be an important player in Treg-mediated suppression. 
 Treg may also create a local environment that is unfavorable for effector T cell 
development. Treg may take up the IL-2 in their vicinity via their constitutive expression 
of the high-affinity IL-2 receptor α chain, CD25, leaving their immediate environment 
deficient in IL-2. This could cause the apoptosis of target cells as a result of cytokine 
deficiency, a theory that is supported by reports of Teff apoptosis following exposure to 
Treg in a process that depends upon expression of the pro-apoptotic factor Bim in the 
Teff [62]. Additionally, Treg have been shown to express high levels of the ectoenzymes 
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CD39 and CD73, which catalyze the breakdown of extracellular ATP or ADP into 
adenosine [63]. Adenosine binds to the adenosine receptor 2A on Teff and can inhibit 
their function. 
 Treg may also mediate their suppressive effects by altering the function of the 
APC, particularly dendritic cells (DC), that present the antigens to the target T cells. 
Intravital microscopy has revealed direct interactions between antigen-specific Treg and 
DC in vivo within hours after transfer [64, 65], and the presence of Treg shortens the 
interactions between Teff and DC (65). These interactions may directly inhibit the ability 
of Teff to interact with DC (by “crowding”), as well as directly alter the characteristics of 
the DC as to reduce its ability to subsequently present antigen to the Teff, and/or cause it 
to enhance the proliferation and generation of Treg.  
 In terms of decreasing the DC’s ability to activate a Teff cell, Treg have been 
shown to condition DC to express indolamine 2,3-dioxygenase (IDO), which can cause 
suppression by breakdown of tryptophan into pro-apoptotic molecules [66]. Additionally, 
interaction with Treg has been shown to result in a downregulation of the costimulatory 
molecules CD80 and CD86 on the DC, thereby inhibiting its ability to activate a naïve T 
cell [67]. These effects on DC are dependent upon the expression of CTLA-4 by the 
Treg, which engages CD80 and/or CD86 on the DC; in the absence of CTLA-4 
expression or in presence of blocking antibody there was a reduction of Treg-mediated 
suppression via DCs [13, 68]. 
 It is also possible that the Treg is able to change the phenotype of the DC to 
become “tolerogenic”. Treg have the potential to activate latent TGF-β on the surface of 
DC by their production of the enzyme furin in response to environmental IL-12, and this 
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TGF-β may then go on to promote the differentiation of conventional T cells into Foxp3+ 
Treg [69]. This could help to explain the phenomenon of infectious tolerance, by which 
Treg with one specificity can go on to promote tolerance to a second antigen presented on 
the same tissue or cell [70, 71]. In these situations, the original population of Treg is then 
no longer required to maintain tolerance, suggesting that T cells of a new specificity were 
generated.  
 The absence of any one of the aforementioned molecules does not cause a 
complete of loss of suppressive activity akin to a Foxp3 deficiency; this leads to the 
theory that all of these mechanisms play but a part in the overall ability of Treg to 
maintain order. It has been postulated that different mechanisms of suppression come into 
play during different scenarios; in the most “challenging” situations, all of these 
mechanisms may need to work together to keep the immune system fully in check [49]. 
For example, in the case of inflammatory bowel disease (IBD), an array of mechanisms 
may be required due to the great inflammatory potential of this microbial-laden mucosal 
surface, while a more slowly progressing autoimmune disease in a sterile organ, such as 
type I diabetes, may not require as many suppressive mechanisms to control. 
 
T cell receptor specificity in Treg function 
 There has been some controversy over the need for regulatory T cells to 
specifically recognize an antigen from the same cells or tissues to which it is preventing 
an inappropriate immune response. Some reports suggest that the mere presence of a Treg 
of any specificity will suppress the effector T cells in the vicinity, such as in a model of 
autoimmune gastritis that was prevented by the transfer of polyclonal, wild-type Treg 
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[72]. This may be due to the “bystander effect”, in which a Treg is activated by 
recognition of antigen and can then go on to suppress cells of other specificities [73]. 
However, in a follow-up report the same group reported that antigen-specific Treg were 
much more efficient at preventing disease [74]. The very opposite has also been reported, 
in a system where TCR transgenic Treg cells of known antigen specificity only 
suppressed cells with the same antigen specificity [75]. And while several reports have 
established a need for TCR engagement for Treg function [51, 76], there is also a report 
showing that Treg can suppress T cells with a completely different antigen specificity, in 
the absence of TCR engagement [77].  
 Evidence for antigen specificity in the Treg population has been observed in 
models which show a lack of suppressive capability for a tissue or organ which is absent 
in the animal in which the Treg developed. For example, in the prevention of 
autoimmune prostatitis due to day 3 thymectomy, T cells isolated from male mice were 
more effective than those from female mice or from males that had been orchidectomized 
just after birth [78]. Similarly, in a model of autoimmune thyroiditis in rats, disease was 
prevented by the transfer of a CD4+ regulatory subset from rats with an intact thyroid but 
not by cells from rats whose thyroids were ablated in utero by 131I treatment [79]. These 
studies suggest that the development and/or maintenance of Treg capable of controlling 
autoimmunity of a particular tissue depends upon the presence of that tissue. 
 A skewing towards self-antigen reactivity has been demonstrated for Treg [37], 
supporting the hypothesis that Treg maintain tolerance by direct recognition of the 
antigens of the cells and tissues they are protecting. Additionally, it has been shown that 
Treg capable of preventing autoimmunity of a particular organ are found preferentially in 
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the draining LN of that organ [80]. However, another report argues that there are no more 
self-reactive TCRs found within the Treg repertoire than the non-Treg repertoire, and that 
most, in fact, could be shown to be non-self antigen responsive [81]. Although this study 
uses an extremely reduced repertoire of TCRs, and its most compelling data relies on 
TCRs selected in an environment in which the MHC display only a single self-peptide, it 
casts doubt on the assumption that the Treg population is highly enriched in self-specific 
T cells.  
 Studies of the repertoires of the Treg and non-Treg populations in the peripheral 
lymphoid organs of mice have reported a varying degree of overlap in the T cell receptors 
used by, and presumably the antigen specificities of, the two subsets [33-35]. This 
variability in results may be due to the different systems used by these groups. 
Additionally, a more recent study suggests that these overlapping TCRs may belong to 
“unstable” Treg, which tend to express lower levels of Foxp3 and appear to be the result 
of conversion of non-Treg cells into Foxp3+ T cells [82]. All of these studies, however, 
agree that the TCR repertoire is not the same between the two populations, indicating that 
they develop differently. 
 
The highly specialized immune system of the gut 
 The digestive tract is a portion of the body that presents a unique challenge to the 
immune system; it must prevent disease caused by infectious organisms at this 
environmental interface, while maintaining tolerance to the many beneficial and non-
harmful organisms that are colonized there. It is estimated that the lower gastrointestinal 
tract of the mammal is one of the most complex microbial ecosystems on the planet, 
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harboring over 100 trillion bacteria of 500-1000 different species [83, 84]. The immune 
system must allow the colonization of beneficial symbionts, which provide host benefits 
such as supplying essential nutrients, metabolizing otherwise undigestible compounds, 
and defending against colonization by pathogenic bacteria. On the other hand, it must still 
be capable of recognizing and fighting pathogenic microorganisms to fight disease. When 
the ability to appropriately balance these two goals breaks down, the immune system can 
inappropriately target commensal organisms, resulting in inflammatory bowel diseases 
(IBD) such as Crohn’s disease (CD) or ulcerative colitis (UC).  
 The commensal microbiota is composed of members from all three domains of 
life – eukarya, archaea and bacteria. However, the bacteria are the dominant organisms 
present. The bacteria are acquired during a short period of initial colonization beginning 
immediately after birth, and by adulthood there is a relatively stable community of 
bacteria which can vary from individual to individual, in a way that appears to be partly 
influenced by genetics and partly by environment [85]. The amount of bacteria present 
depends on the location, with there being very little in the stomach and proximal small 
intestine, with increasing amounts in the distal small intestine and colon, resulting in a 
density of approximately 109 – 1012 per ml of luminal contents. 
 Sequencing of the 16S rRNA of the intestinal microbes has allowed for the 
identification of the bacteria that typically inhabit the gut, regardless of the ability to 
culture them in the laboratory. These studies have identified members of the gram-
positive, anaerobic phylum Firmicutes as the most prominent, with the gram-negative 
Bacteroides as the next most prevalent [86]. The remaining phyla make up less than ten 
percent of the population, and include Actinobacteria, Proteobacteria, Fusobacteria and 
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others. The fact that many of these are facultative aerobes may put them at a competitive 
disadvantage and explain their relatively low abundance in the anaerobic environment of 
the gut [87]. 
 The barrier which separates the gut lumen and its microbial contents from the 
body is composed of a single layer of intestinal epithelial cells (IEC) connected by tight 
junctions. Also included in this epithelial layer are the goblet cells, responsible for 
secreting the mucin that forms a layer of mucus which coats the lumen, and the Paneth 
cells, specialized antimicrobial peptide secreting cells found in the base of the crypts of 
the intestine [88]. The mucus that coats the lumen can extend up to 150µm from the 
epithelial surface. Its innermost layer is resistant to bacterial penetration and likely also 
retains secreted antimicrobial peptides, therefore serving as an additional barrier to the 
bacteria that inhabits the lumen [87].  
 Also incorporated into the epithelial layer are the specialized microfold or “M” 
cells, which transporter luminal antigens across the epithelial barrier to the underlying gut 
associated lymphoid tissues (GALT). This provides a source of antigen for the dendritic 
cells (DC) of the GALT, which can then present them to the resident T cells. The 
epithelium also includes a population of specialized T cells, the intraepithelial 
lymphocytes (IEL), which are largely of the “unconventional” CD8αα+ (CD8β–) type, 
many of which express TCRγδ and may assist in the clearing of stressed or damaged IEC, 
and contribute to tolerance by secreting TGFβ upon activation [89]. A population of DC 
have also been described to form tight-junction-like structures with the IECs and project 
dendrites into the lumen in order to sample antigens directly [90]. 
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 Beneath the epithelium in the lamina propria, the loose connective tissue which 
supports the delicate epithelium, are most of the more conventional immune cells of the 
GALT. Organized lymphoid structures include the Peyer’s patches of the small intestine 
and the isolated lymphoid follicles (ILF) of the colon. These serve as the site of T cell 
interaction with antigen-loaded DC, which are known to acquire antigens from the 
intestinal lumen [91, 92]. In addition, B cells are located in these follicles, as well as 
throughout the lamina propria, and produce secretory IgA antibodies which are 
transcytosed across the epithelium by the IEC [93]. These antibodies help to keep the 
intestinal bacteria in the lumen, as shown by increased penetration of symbiotic bacteria 
into the tissues of IgA deficient mice [94, 95]. 
 
The intestinal epithelial cell interaction with the commensal microbiota 
 The microorganisms that peacefully reside in the gut are not just tolerated; they 
constantly interact with and influence the host. With such a large reservoir of 
microorganisms in constant contact with host mucosal surfaces, it is not surprising that 
they have been shown to have an important impact on the immunology of the gut for the 
benefit of both the host and the resident gut organisms. Studies with germ-free and 
gnotobiotic mice have shown that recognition of the commensal microbiota is necessary 
for the normal development of both the mucosal and peripheral immune system [85]. 
Germ-free mice exhibit poorly formed Peyer’s patches, smaller mesenteric lymph nodes 
(MLN), impaired development of isolated lymphoid follicles (ILFs), altered composition 
of the CD4+ T cells and IgA-producing B cells in the lamina propria, and an absence of 
MAIT cells which normally reside in the lamina propria [96, 97]. Additionally, the IEC 
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exhibit a reduced rate of cell turnover, and altered microvilli formation in germ-free 
animals [96].    
 The IEC are the most abundant cells to have direct contact with the microbiota, 
and they play an important role in maintaining intestinal immune tolerance. Their first 
role is to provide a barrier between the bacteria of the gut and the immune system of the 
host. However, the IEC can also sense the bacteria by their expression of pattern 
recognition receptors (PRR), such as toll-like receptors (TLR) and nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs), which bind to a variety of 
conserved ligands derived from microorganisms [98]. The hyporesponsiveness of these 
cells is thought to be a result of several strategies, one simply being the limited contact 
with bacteria, which find it difficult to penetrate the layer of mucus which lines the 
lumen. Mice which lack production of mucin suffer from intestinal inflammation, 
presumably as a result of their inability to form this relatively bacteria-free zone adjacent 
to the epithelium [99].  
 In an additional mechanism to minimize reactivity to the bacteria, the expression 
of TLRs by the IEC is generally quite low, while increased expression is seen in inflamed 
intestines, such as in patients with Crohn’s disease [100]. The TLR expression on the IEL 
may also be limited in order to minimize engagement of bacterial-derived ligands. For 
example, it has been shown that TLR5 expression is normally limited to the basolateral 
side; therefore, TLR5-mediated activation will only occur in response to bacteria that 
have breached the epithelial barrier [101]. In contrast, TLR9 has been shown to be 
expressed on both the apical and basolateral sides of the IEC (unlike in immune cells, it 
does not reside in endosomes), and the response to engagement of the receptor in the two 
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locations is opposite. When administering CpG oligodeoxynucleotides (ODN), a ligand 
for TLR9, on the basolateral side of the cell, NF-κB was activated and led to the secretion 
of the inflammatory cytokine IL-8 [102]. However, when TLR9 was engaged on the 
apical surface, NF-κB was inhibited. This sort of spatial segregation can emphasize 
tolerance to bacteria encountered in the lumen, but still allow for a vigorous immune 
response to bacteria that have breeched the epithelial barrier. 
 The IEC also appear to actively dampen the response to engagement of TLRs and 
other PRR when it does occur. For example, IEC express a negative regulator of TLR and 
IL-1R signaling called SIGIRR (single-immunoglobulin-domain-containing interleukin-1 
receptor-related protein), and in the absence of this they express an increased level of 
pro-inflammatory genes, and increased susceptibility to commensal bacteria-dependent 
intestinal inflammation [103]. They also express the protein A20, which acts to inhibit 
NF-kB activation, and mice deficient in A20 develop severe intestinal inflammation [104, 
105]. It is also thought that certain commensal bacteria are capable of actively 
suppressing the immune response by inhibiting NF-kB activation. Both nonpathogenic 
Salmonella strains and Bacteroides thetaiotamicron have been shown to interfere with 
NF-kB activation, although by different mechanisms [106, 107]. In addition, some 
products of commensal bacteria metabolism are immunomodulatory, such as butyrate 
that is produced by the digestion of starch, which can inhibit the production of pro-
inflammatory cytokines [108]. 
 IECs respond to contact with bacteria in ways which impact and instruct the 
immune system. Engagement of TLRs can cause NF-kB activation, leading to the 
increased production of thymic stromal lymphopoietin (TSLP), which is thought to have 
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a tolerogenic effect on the intestinal DC [109, 110]. TSLP has been shown to restrict the 
production of IL-12 and promote IL-10 production by DC, and therefore may play a vital 
role in conditioning lamina propria DC to be tolerogenic. IEC also produce TGFβ, which 
can inhibit the expression of pro-inflammatory cytokines by macrophages and DC, and 
inhibit the expression of MHC class II and costimulatory molecules [111, 112]. The 
production of prostaglandin E2 (PGE2) by the IEC can contribute to the maintenance of 
tolerance to dietary antigens, by an unknown mechanism involving the inhibition of T 
cell proliferation [113]. This may be due to the induction of IL-10 and IDO production by 
DC [114, 115]. Upon TLR engagement IEC can also influence B cells by the production 
of APRIL, a B cell stimulating factor which can promote plasma cell survival and class 
switching to IgA [116]. IEC also express MHC class II molecules, and while they lack 
the costimulatory molecules necessary to prime naïve T cell responses, they are capable 
of activating antigen-experienced T cells, and may induce anergy in naive T cells due to 
this lack of costimulation [117]. Antigen processing and presentation by IEC has been 
shown to occur in a polarized fashion, with antigens obtained on the apical side of the 
cell and presented on the basolateral side [118]. 
 
The Unique Role and Properties of Intestinal Dendritic Cells 
 Antigen presenting cells are also in contact, both directly and indirectly, with the 
commensal microbiota and are central to mediating the immune response to it. The 
dendritic cells (DC) found in the intestine are different in their phenotype and functional 
properties than those found elsewhere in the body, and multiple types have been 
identified. These are generally identified by their high expression of CD11c, and then by 
-23- 
the expression of either CD11b, CD8α, or neither, forming three main categories of 
conventional DC in the gut immune system [119, 120]. These different subsets tend to be 
found in different locations, with the CD11b+ DC concentrated in the sub-epithelial dome 
of the Peyer’s patch, and the CD8α+ DC in the interfollicular regions. There are also 
many DC present in the lamina propria of the small intestine, but in the colon most DC 
are found within the isolated lymphoid follicles (ILF) under steady state conditions [121].  
 The DCs can obtain antigens from the commensal microbiota in multiple ways. 
The CD11b+ DC located in the sub-epithelial dome are positioned to receive bacteria and 
bacterial antigens transported from the gut lumen by M cells. This subset has a higher 
capacity to produce IL-10 and to prime a TH2 (rather than TH1) T cell response to 
infection, and therefore may help mediate tolerance to the gut antigens constitutively 
transcytosed by the M cells [120]. Uptake of small numbers of commensal bacteria by 
this route has been shown to induce production of IgA, which would serve to limit 
bacterial penetration, and therefore may limit the potential for destructive inflammatory 
responses to develop to the bacteria [95]. Lamina propria DC expressing the chemokine 
receptor CX3CR1 can also form tight-junction-like structures with the IEC and extend 
dendrites through the epithelial barrier to directly sample luminal contents [90]. This 
ability to penetrate the epithelium may also allow for DCs to engulf apoptotic epithelial 
cells, and thereby process and present antigens from them. 
 DCs which take up antigen in the intestine may constitutively migrate to the 
MLN, where they can present antigen to T cells. These DC have obtained antigen in close 
proximity to the IEC, and as discussed earlier, may be affected by the production of 
tolerogenic molecules by the IEC under non-inflammatory conditions. Intestinal dendritic 
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cells can be subdivided by their expression of the αE integrin, CD103. Those which 
migrate through the lymph to the MLN tend to be CD103+, while the CD103– subset 
found in the MLN are thought to be resident DC which have developed from blood-borne 
precursors. CD103+ DC have the ability to promote expression of the gut-homing 
receptors α4β7 (which binds to MadCAM1 on the vascular endothelium of the 
gastrointestinal tract) and CCR9 (whose ligand CCL25 is produced by IEC) on CD4+ T 
cells, likely including regulatory T cells which are induced in the lymph nodes [122, 
123]. CD103+ DC carrying antigens from the intestine are implicated in the development 
of Foxp3+ Treg from naïve Foxp3– T cells; CD103+ DC isolated from the MLN were 
shown to mediate the development of Treg in vitro in a TGFβ-dependent manner, while 
the CD103– subset did not [124]. In one study, bone marrow-derived dendritic cells 
(BMDC) were capable of internalizing the commensal bacterium Lactobacillus 
rhamnosus while maintaining an immature phenotype, and were able to prevent intestinal 
disase upon transfer into a recipient animal by a mechanism that depended upon the 
presence of CD4+CD25+ T cells [125]. Presumably, therefore, intestinal DC would be 
capable of internalizing commensal bacteria in the intestine and trafficking to the MLN, 
where they could expand and/or convert regulatory T cells, as well as causing them to 
upregulate gut-homing receptors, therefore sending them to the intestine to mediate 
tolerance to that bacterium. 
 The ability of DC to induce B cell class switching to IgA, convert naïve T cells 
into Foxp3+ Treg, and induce gut-homing molecules may all be due at least in part to the 
production of retinoic acid (RA) by these DC. Retinoic acid is a product of vitamin A 
metabolism, and vitamin A deficiency is reported to lead to low levels of IgA [126], and 
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T cell independent class switching mediated by DCs isolated from the Peyer’s patch has 
been shown to depend upon RA and IL-5 or IL-6 [127]. RA has been shown to enhance 
TGFβ dependent conversion of naïve T cells into Foxp3+ Treg and to induce gut homing 
molecules [44, 124, 128-130]. Accordingly, MLN CD103+ DCs express higher levels of 
one of the enzymes involved in the production of RA from vitamin A, aldehyde 
dehydrogenase family 1, subfamily A2 (ALDH1A2), than their CD103– counterparts 
[124]. Additionally, the IEC have been shown to express the closely related ALDH1A1, 
so they can also produce RA which can be taken up and transported by DCs [131, 132]. 
 These data suggest a scenario in which the “decision” of whether to respond to the 
detection of a bacteria rests on the way in which the dendritic cell acquires the antigen. If 
a DC is in close proximity to the IEC, it can acquire the antigen in a way that promotes a 
non-inflammatory response; as CD103 expression allows interaction of the DC with E-
cadherin expressed on the IEC, it would follow that the CD103+ DC are the ones which 
have done this. These DC then go on to promote tolerance to these antigens, by inducing 
and/or enhancing regulatory T cell responses and B cell production of IgA directed at 
these antigens. On the other hand, if a DC encounters a bacterium in an area that is not in 
close vicinity to the IEC, such as the lamina propria or MLN, it is likely that the bacteria 
has actively invaded the epithelium. This DC was not in close contact with the IEC, did 
not undergo “conditioning”, and is still capable of mediating attack to this organism. In 
the absence of “conditioning”, the CD103– DC would tend to prime a TH1 response, as 
this subset has been shown to produce more IFNγ [122]. In addition, IEC would no 
longer be secreting tolerogenic molecules, in response to the epithelial cell invasion or 
epithelial layer breech, allowing for engagement of PRR which would normally be 
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sequestered (such cytosolic NOD2 or basolaterally-expressed TLR5). They would 
therefore not downregulate DC maturation and inflammatory cytokine production, further 
driving the immune response. 
 
The loss of tolerance to the commensal microbiota results in inflammatory bowel disease. 
 In humans, inflammatory bowel disease is a serious clinical problem, affecting 0.1 
– 0.2% of the population in the form of Crohn’s disease and Ulcerative Colitis [133]. 
Disease susceptibility, as with most autoimmune disorders, appears to be a combination 
of genetic predisposition and unknown environmental triggers [134]. There is evidence 
that disease is dependent upon and affected by the resident bacteria in the gut, as 
antibiotic treatment often ameliorates disease in IBD patients, and they show higher 
antibody titers against commensal bacteria than unaffected individuals [135, 136]. Also, 
individuals with IBD show an altered community of commensal bacteria compared to 
healthy controls. In most mouse models of IBD disease does not develop in the absence 
of bacteria. 
 The prevailing view of IBD is that it is the result of a dysregulated inflammatory 
response and/or innate immunodeficiency to the commensal microorganisms in the gut 
[137]. Failures in the mucosal barrier (due to targeting by a pathogen or genetic 
mutations such as NF-kB deficiency) and defective defensin production by Paneth cells 
(due to mutations in the intracellular peptidoglycan derivitive detector NOD2 or a defect 
in autophagy) are failures of the innate immune system which can allow the microbiota to 
become uncontrolled [138-140]. In addition, a dysregulated response to the sensing of 
bacteria can cause an inappropriate or exaggerated inflammatory response. This can be 
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due to defective TLR signaling, which is required to maintain intestinal homeostasis and 
repair, promotes luminal antigen sampling by DCs and usually causes production of anti-
inflammatory cytokines by the IECs [109, 141, 142]. However, inappropriate responses 
to TLR signals in may also occur, due to a lack of molecules that usually dampen the 
TLR response in these cells, such as A20 or SIGIRR (mentioned earlier) [103, 104]. A 
lack of anti-inflammatory cytokines such as IL-10 or TGFβ can also cause intestinal 
disease, as shown by the spontaneous development of colitis in mice with IL-10, IL-10 
receptor, TGFβ, or TGFβ receptor signaling deficiencies [143]. These cytokines have 
effects both on the activation state of the antigen presenting cells as well as the on the B 
and T cells directly. The downstream effect of all of these innate immune system 
deficiencies is a failure to establish or maintain tolerance in the adaptive immune system, 
resulting in an inappropriately directed adaptive immune response. 
 While there are many cell types and mechanisms involved in the maintenance of 
intestinal tolerance, Foxp3+ regulatory T cells are an essential component. One of the 
earliest and most prevalent disorders seen in the IPEX disorder (resulting from Foxp3 
mutations in humans), often leading to the diagnosis, is severe early-onset enteropathy 
[144]. Crohn’s Disease and Ulcerative Colitis are believed to be T cell mediated diseases, 
and are associated with increased pro-inflammatory cytokines such as TNF and IFNγ. It 
has been shown that normal mice harbor effector T cells in the MLN and colonic lamina 
propria which recognize intestinal bacteria, and these are actively restrained by the 
CD4+CD25+ cells from the GALT. [145]. This is the basis of a classic model used in the 
study of colitis first described by Fiona Powrie [146]. In this model, a population of non-
regulatory T cells is transferred into a T cell deficient host, where they undergo 
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homeostatic expansion. This leads to the development of spontaneous colitis upon the 
arrival of effector T cells into the gut in the absence of Treg. Therefore, disease can be 
prevented by the co-transfer of a population of Treg, providing a model that allows the 
requirements for Treg suppressive activity in the gut to be elucidated.    
 Whether Treg in the gut need to be specific for intestinal (self or commensal-
derived) antigens to maintain homeostasis is uncertain. Some evidence suggests that Treg 
specific for gut antigens are more efficient at preventing disease. In at least one study, 
Treg cells isolated from germ free mice could not protect from disease in the transfer 
model of colitis [147]. In another study, germ-free Treg were capable of preventing 
disease, but not as efficiently as the conventional Treg [148]. This somewhat reduced 
ability to suppress may rely on Treg that recognize conserved self antigens found in the 
gut, allowing for their activation and suppressive function even in the absence of bacterial 
recognition. Alternatively, in the absence of commensal bacteria, the Treg may be less 
activated, and therefore less suppressive no matter their specificity. Models of oral 
tolerance, however, have been shown to involve the induction of antigen-specific Treg 
cells. In these studies, DO11.10 TCR transgenic T cells specific for an ovalbumin (OVA) 
peptide became Foxp3+ in the MLN and small intestine LP only after feeding the mice 
OVA [124].  
 With the importance of Treg in the maintenance of tolerance in the intestines, it 
seems reasonable that the ability to induce Treg at this location would confer the 
flexibility that is required to maintain tolerance in a location with such a dynamic 
antigenic profile. The increased propensity for peripheral conversion of non-regulatory 
cells into Foxp3+ Treg in the GALT as compared to the “central” immune system has 
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been reported. As previously mentioned, upon transfer of non-Treg into a lymphopenic 
host (with co-transfer of whole CD4+ T cells to prevent intestinal inflammation) there 
were 4-5 times more converted Treg recovered in the MLN and small intestine lamina 
propria (LP) than in peripheral LN or ear dermis [44]. Additionally, a recent study of the 
role of the conserved non-coding sequences (CNS) in the foxp3 gene that one of these 
sequences was required specifically for conversion of a mature non-regulatory cell into a 
Foxp3+ regulatory cell in vitro. In the mice harboring a deletion in this sequence, a 
selective decrease was seen in Foxp3+ Treg in the GALT [149]. Most likely conversion is 
prominent in the gut due to the presence of the CD103+ DC, which have been shown to 
be efficient at inducing Foxp3+ T cells due to their ability to provide retinoic acid (RA) 
and TGFβ alongside TCR engagement. These cells have been shown to migrate to the 
lymph nodes carrying intestinal antigens including bacteria, and are therefore poised to 
divert T cells with specificity for bacterial antigens into the regulatory lineage. 
 
Summary 
 The CD4+Foxp3+ regulatory T cell subset is of vital importance in the 
maintenance of peripheral tolerance to both self antigens and harmless foreign antigens 
such as those derived from food or commensal bacteria. The specific mechanisms by 
which Treg assert their suppressive ability are still unclear, with many different candidate 
mechanisms having been described. Most likely some combination of these mechanisms 
is employed, with some variability according to the situation, and some redundancies that 
highlight the importance of their function. The challenge of maintenaning tolerance while 
keeping the ability to provide an immune response to pathogens is particularly 
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challenging in areas of the body in contact with the microorganisms that inhabit our 
surroundings. The immune system of the gut meets this challenge with a complicated and 
unique set of solutions, among them the regulatory T cells that are essential for 
preventing inappropriate responses to the commensal microbiota. What role Treg 
specificity plays in their function remains undefined, as there are conflicting data 
concerning their ability to suppress immune responses in an antigen non-specific way.
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Chapter Two: Preface 
 The studies described in this chapter were a direct result of previous work done by 
my thesis advisor, Dr. Chyi Hsieh, while a postdoctoral fellow in the laboratory of Dr. 
Alexander Rudensky at the University of Washington. It was known that Foxp3+ 
regulatory T cells emerged from the thymus with this phenotype, but it was not certain 
whether they were selected on the basis of a unique TCR specificity or were randomly 
selected. The use of a transgenic mouse expressing a fixed TCRβ chain to sequence a 
subset of the TCRα chains to get a measurement of the TCR repertoire of the Treg and 
non-Treg populations proved to be an elegant way to answer this question at the 
individual sequence level.  As was suspected, these populations showed only slight 
overlap in their TCR usage, suggesting that they recognize different populations of 
antigens. These studies went on to show evidence that many of these appear to be self 
antigens, as T cells expressing these Treg-derived receptors expanded preferentially upon 
transfer to lymphopenic hosts [37].   
 While these studies showed that regulatory and non-regulatory cells used a 
different repertoire of TCRs, they left unaddressed the possibility that the regulatory T 
cells may show similarity to antigen-experienced memory T cells. It has been proposed 
that upon antigen recognition a naïve T cell may give rise to both effector T cells (a TH1 
cell, for example) and a regulatory T cells, in order to limit the extent of the immune 
response [45]. The previous studies did not differentiate between non-regulatory cells of 
a naïve and a memory phenotype; as 90% of the non-regulatory population in these mice 
is usually of a naive phenotype, the main comparison previously made was between naïve 
and regulatory T cells. 
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 Additionally, the T cells sequenced in the previous studies were a mix of cells 
from the spleen and lymph nodes. There have been reports suggesting that Treg act in an 
antigen-specific manner to prevent autoimmunity, and the presence of a tissue is required 
to develop and maintain Treg specific for that particular tissue [79]. In addition, data 
suggested that the Treg would be located preferentially in the draining lymph node of that 
tissue [80]. Therefore, the studies described in this chapter were designed to answer these 
questions. The results of this work were published in The Journal of Experimental 
Medicine in 2008 and this chapter is adapted from this manuscript [150]. 
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Chapter Two: Abstract 
 Although regulatory T (Treg) cells are thought to develop primarily in the thymus, the 
peripheral events that shape the protective Treg cell population are unclear.  Here, we 
analyzed the peripheral CD4+ TCR repertoire by cellular phenotype and location in mice 
with a fixed TCRβ chain.  We found that Treg (Foxp3+) cells showed a marked skewing 
of TCR usage by anatomic location in a manner similar to antigen-experienced 
(CD44hiFoxp3–), but not naïve (CD44loFoxp3–), cells, even though CD44hi and Treg cells 
used mostly dissimilar TCRs.  This was likely unrelated to peripheral conversion, which 
we estimate generates only a small percentage of peripheral Treg cells in adults. 
Conversion was readily observed, however, during the immune response induced by 
Foxp3– cells in lymphopenic hosts.  Interestingly, the converted Foxp3+ and expanded 
Foxp3– TCR repertoires were different, suggesting that generation of Foxp3+ cells is not 
an automatic process upon antigen activation of Foxp3– T cells.  Retroviral expression of 
these TCRs in primary monoclonal T cells confirmed that conversion did not require 
prior cellular conditioning.  Thus, these data demonstrate that TCR specificity plays a 
crucial role in the process of peripheral conversion and in shaping the peripheral Treg cell 
population to the local antigenic landscape.   
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Chapter Two: Introduction 
 The importance of natural Foxp3+ regulatory T (Treg) cells for the maintenance of 
self-tolerance was recently reaffirmed by the observation that acute depletion of Treg 
cells creates a state of “immunologic anarchy”, resulting in the rapid death of a 
previously healthy animal [30, 151].  Treg cells are commonly thought to be generated in 
the thymus due to recognition of self-antigens [36, 152], which is supported by studies 
using mice with limited T cell receptor (TCR) diversity showing strong similarity 
between the thymic and peripheral Treg TCR repertoires [33, 34, 153].  However, the 
peripheral and thymic Treg TCR repertoires were not identical, suggesting that certain 
TCRs are preferentially enriched or deleted in the periphery, akin to earlier observations 
in the total CD4+ T cell population [154].  
 The notion that post-thymic Treg TCR repertoire shaping may play an important role 
in immune regulation was suggested by a number of studies demonstrating that the 
presence of an organ is accompanied by functionally enhanced suppression of 
autoimmunity to that organ [78-80, 155].  Based on these studies, it has been widely 
hypothesized that tissue-specific Treg cell number is increased due to the presence of the 
antigen.  However, this has not been directly demonstrated, and alternative explanations 
for these classic observations include altered trafficking patterns [128, 130, 156] and 
activation status [155, 157] of Treg cells at particular locations. These other possibilities 
are consistent with reports suggesting that Treg cells may not require tissue specificity for 
suppression [158-160], nor recognize self-antigens [81].  Thus, an important unresolved 
question is whether the peripheral Treg TCR repertoire is altered based on the 
presentation of tissue-specific antigens.   
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 The development of Foxp3+ T cells from mature, naïve Foxp3– T cells, a process 
often referred to as peripheral conversion, is another mechanism by which the peripheral 
repertoire may be altered.  This process would allow for the generation of Treg cells 
specific for antigens not presented in the thymus, such as those from commensal 
microbiota or sequestered self-antigens [45, 161].  Furthermore, it has been hypothesized 
that peripheral conversion may also generate Treg cells during the course of an immune 
response to limit immune pathology.  Studies of TCRαβ transgenic T cells have shown 
that exposure to cognate antigen under non-inflammatory or tolerogenic conditions in 
vivo results in the development of suppressive Foxp3+ Treg cells in a portion of the 
monoclonal T cell population [39, 41, 162].  In polyclonal T cell populations, peripheral 
development of CD25+ cells characteristic of Treg cells has been observed after adoptive 
transfer of CD25– T cells into both lymphopenic and non-lymphopenic hosts [42, 43].  
However, a study using endogenous secondary TCRα chains on self-reactive BDC2.5 
TCRαβ transgenic T cells to track T cell fates found no evidence that this TCR facilitates 
conversion [35].  Thus, the role of peripheral conversion in generating the peripheral 
Treg cell population remains unresolved.   
  To address these questions, we analyzed the TCR repertoire based on anatomic 
location and cellular phenotype by sequencing TCRα chains in mice with a fixed TCRβ 
chain [37].  We generated a database of nearly 18,000 TRAV14 (Vα2) TCRα chain 
sequences derived from Treg (Foxp3+), antigen-experienced (CD44hiFoxp3–), and naïve 
(CD44loFoxp3–) CD4+ cells isolated from the spleen; and cervical, axillary, inguinal, and 
mesenteric lymph nodes. We found considerable differences in TCR usage by location in 
the Treg and CD44hi, but not CD44lo, T cell populations, demonstrating that tissue-
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specific antigen recognition dramatically alters the peripheral Treg cell population. 
Shaping of the peripheral Treg TCR repertoire by location therefore suggests that 
immune regulation is a tissue-specific activity.   
 A potential explanation for parallel changes in both the Treg and CD44hi TCR 
repertoires by location is that peripheral conversion generates a large proportion of the 
peripheral Treg cell population.  However, we found that few cells (~0.03%) became 
Foxp3+ after adoptive transfer of Foxp3– cells into normal adult hosts, resulting in an 
estimated 3% contribution to the peripheral Treg cell population.  By contrast, we found a 
much higher percentage of conversion during the immune response induced by Foxp3– 
cells transferred into lymphopenic hosts.  Interestingly, there was considerable disparity 
in TCR usage between the converted Foxp3+ and expanded Foxp3– T cell subsets within 
the same individual host.  We excluded an absolute requirement for thymically-derived 
Treg cell precursors by showing that retroviral expression of particular TCRs on 
monoclonal peripheral T cells was sufficient to permit peripheral conversion.  Thus, these 
data favor a TCR-specific model of peripheral Treg cell development.   
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Chapter Two: Materials and Methods 
Mice and Reagents 
 Foxp3gfp reporter knockin, and TCli TCR-β and TCR-αβ transgenic mice were kindly 
provided by Dr. Alexander Rudensky (U. Washington, Seattle, WA). B6.SJL (CD45.1), 
B6.PL (Thy1.1), Tcrb–/–, and Tcra–/– mice were obtained from the Jackson Laboratory 
(Bar Harbor, ME). Animals were housed in a specific-pathogen-free animal facility at 
Washington University and were used according to protocols approved by the 
Institutional Animal Care and Use Committee. Monoclonal antibodies were purchased 
from eBioscience (San Diego, CA) and Becton Dickenson (San Jose, CA). Human IL-2 
was obtained from the NIH Biological Resources Branch (Frederick, MD).  
 
Cell purification 
CD4+ T cells were initially purified from the indicated tissues using the CD4 
Untouched kit, which utilizes AutoMACS magnetic separation to remove non-CD4+ cells 
(Miltenyi Biotech, Auburn, CA). Remaining cells were stained with fluorescently labeled 
antibodies and sorted by flow cytometry using a Moflo (Dako, Carpinteria, CA) or a 
FACSAria (Becton Dickenson).  
 
Isolation of T cells for TCR sequencing 
 CD4+Vβ6+ T cells were purified by FACS into the Foxp3+, Foxp3–CD44hi, and 
Foxp3–CD44lo subsets from normal mice, and Foxp3+ and Foxp3– subsets after 
proliferation and conversion in lymphopenic hosts. CD44 was not used to purify T cells 
from lymphopenic hosts as the Foxp3– population was CD44hi after lymphopenia-induced 
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proliferation. Post-sort purity was > 95%. The percentage of Vα2+ cells was found to 
range from 6-14%, suggesting that the proportion of these cells was relatively stable 
between mice and experiments. Cloning of TRAV14 TCRα sequences was performed as 
previously described [33]. As before, we utilized the CDR3 amino acid sequence 
provided by IMGT/V-QUEST as a unique identifier for individual TCRs [163]. Thymic 
Foxp3+ and Foxp3– CD4+CD8– data sets have been previously described [164].  
 
Statistical Analysis 
 The estimated contribution of peripheral conversion to the Treg cell population is a 
simple extrapolation of the % Foxp3+ in the adoptively transferred Foxp3– population to 
the entire Foxp3– population multiplied by the proportion of Foxp3– cells of CD4+ T 
cells, divided by the proportion of Treg cells of CD4+ T cells. Thus, an 8% conversion in 
normal mice would represent 7.2% of total CD4+ T cells (8% x 90%), which would be 
72% the size of the Treg subset (7.2% of 10% Treg cells in the total CD4+ T cell 
population).  
 We used the Morisita-Horn index as a statistical measure of similarity between two 
data sets [165]. This unit-less index ranges from 0 to 1, representing complete 
dissimilarity to similarity. The Morisita-Horn index takes into account the frequency of 
each TCR, and is relatively resistant to the sample size, as compared with other similarity 
indices such as the Jaccard. A sequence found in both data sets at greatly different 
frequencies would therefore contribute to dissimilarity by this index. For reference, 
comparison of the first 200 sequences with the last 200 sequences of an ~400 sequence 
data set results in a Morisita-Horn index of about 0.9, which represents an experimentally 
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derived value for the maximum expected similarity, incorporating the inherent variability 
due to random sampling.  
 The abundance coverage estimator (ACE) was used to estimate the total number of 
unique species in the population based on the observed number of species in the data set 
as previously described [37]. 
 To determine whether anatomic location affected TCR distribution, we performed 
generalized linear model testing using the raw counts of all experiments for each of the 
phenotypes. We utilized the Bonferroni correction (0.05 divided by the total number of 
sequences analyzed) to provide the most stringent p-value for rejection of the null 
hypothesis, that TCR distribution is unaffected by location.  
 
Assessment of Peripheral Conversion in vivo 
 For non-lymphopenic hosts, 107 FACS purified Foxp3–CD4+CD45.2+ T cells from 
the pooled spleen and lymph nodes of Foxp3gfp mice were intravenously injected into 
congenic Thy1.1 hosts. One to two hundred Foxp3+CD4+CD45.1+ T cells were also co-
transferred to assess the contribution of Foxp3+ contaminants in the Foxp3– population. 
Acquisition of Foxp3 and other markers by flow cytometry was assessed after 3-4 weeks.  
 For lymphopenic hosts, 2x106 FACS purified Foxp3–CD4+ T cells from Foxp3gfp or 
TCli TCR-β x Foxp3gfp x TCRα+/– were intravenously injected into Tcrb–/– hosts, and 
analyzed for acquisition of Foxp3 and other markers by flow cytometry after 19-21 days. 
This time point was chosen to diminish the degree of immune activation following 
transfer of non-Treg cells into lymphopenic hosts seen at later time points, while earlier 
time points showed a lower frequency of Foxp3+ cells (data not shown). We also verified 
-41- 
that the converted Foxp3+ cells were unlikely to originate from the contaminating Foxp3+ 
cells in the sorted population using “spike” experiments similar to that in Fig. 2.8 A (data 
not shown). The percentage of Foxp3+ cells was somewhat higher when TCli TCRβ 
chain transgenic T cells were used as compared to non-TCR-β transgenic T cells, but the 
anatomic variation in the frequency of Foxp3+ cells remained consistent (data not 
shown). This is likely due to the constraint on the TCR repertoire imposed by the fixed 
TCRβ chain, but should not affect the determination of whether individual TCRs are 
preferentially found in the converted versus expanded T cell populations. 
 
Facilitation of peripheral conversion by retrovirally expressed TCRα chains 
 Peripheral T cells from TCli (Vα18, Vβ6) TCR-αβ transgenic x Foxp3gfp x Rag1–/– 
mice were depleted by magnetic bead selection of CD25+ cells (Miltenyi), and then 
retrovirally transduced on days 1 and 2 post activation as previously described [33]. After 
7 days, a T cell population containing 4x105 transduced Vα2+CD4+ cells was injected 
intravenously into a Tcrb–/– host. Acquisition of Foxp3 on Vα2+ cells was assessed at 2.5-
3 weeks by flow cytometry.  
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Chapter Two: Results 
Mapping the peripheral CD4+ TCR repertoire    
 To determine the impact of anatomic location and cellular phenotype on the 
peripheral CD4+ TCR repertoire, we isolated Treg (Foxp3+), antigen-experienced 
(CD44hiFoxp3–), and naïve (CD44loFoxp3–), CD4+ cells from the spleen and cervical, 
axillary, inguinal, and mesenteric lymph nodes of TCli TCRβ transgenic x Foxp3gfp x 
Tcra+/– mice (Fig. 2.1).  We considered using CD62L as an additional putative memory 
cell marker, but found that only a minor subset of CD44hi cells are CD62Lhi (data not 
shown).  We obtained TRAV14 (Vα2) TCRα sequences as previously described [33] 
from four independent experiments; three experiments which each consisted of pooled 
cells from 3-5 mice, and a fourth experiment in which three mice were individually 
sequenced. As before, we utilized the CDR3 amino acid sequence as the primary 
identifier for a unique TCR sequence [33]. Approximately 6,000 sequences were 
obtained from each of the Treg, naïve, and memory cell populations, for a total of nearly 
18,000 sequences.   
 
The Treg TCR repertoire varies by anatomic location.   
 An important unresolved issue is the mechanism by which tissue-specific antigen 
presentation results in enhanced protection from autoimmunity, as it could derive from 
either an increased number or heightened potency of antigen-specific Treg cells. Analysis 
of TCRs from the various lymph nodes and the spleen revealed that the Treg TCR 
repertoire varied considerably according to the anatomic location. This could be observed 
both at the level of individual TCRs (Fig. 2.2, 2.3A), and by a statistical assessment of  
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Figure 2.1  Generation of the peripheral TCR database (A) FACS purification 
strategy. Representative flow cytometric plot of CD4+ splenocytes from TCli TCRβ 
transgenic x Foxp3gfp x Tcra+/– mice illustrate the three sorted populations: CD44hi, 
CD44lo, and Foxp3+. Numbers indicate percentages in the gates. (B) Sequence datasets 
from normal mice. The number of TRAV14 (Va2) TCRa chain sequences from T cell 
subsets at each location are shown. Experiment numbers 1–3 consisted of cells pooled 
from three to five mice, whereas experiment 4 consisted of three independently 
sequenced mice. Cells from axillary and inguinal LNs were not isolated in experiment 4, 
as indicated by asterisks. Axil, axillary; Cerv, cervical; Ing, inguinal; Mes, mesenteric.  
Lymph node
Expt. Phenotype Spleen   Mes   Cerv   Axil   Ing Total
1 Foxp3+ 322 298 329 285 357 1,591
CD44hi 295 330 246 305 291 1,467
CD44lo 315 306 307 335 274 1,537
2 Foxp3+ 330 298 301 333 304 1,566
CD44hi 268 321 321 321 298 1,529
CD44lo 333 338 344 344 333 1,692
3 Foxp3+ 283 361 284 298 280 1,506
CD44hi 283 276 365 311 377 1,612
CD44lo 278 306 278 330 453 1,645
4 Foxp3+ 146 161 179 * * 486
mouse 1 CD44hi 154 198 139 * * 491
CD44lo 110 123 167 * * 400
4 Foxp3+ 141 120 164 * * 425
mouse 2 CD44hi 136 143 116 * * 395
CD44lo 113 120 115 * * 348
4 Foxp3+ 122 153 124 * * 399
mouse 3 CD44hi 161 149 143 * * 453
CD44lo 114 152 115 * * 381
Total: 3,870 4,124 4,003 2,959 2,967 17,923
A
C
D
44
716
75
Foxp3
B
Figure 2.1 Generation of the peripheral TCR database.
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Figure 2.2  Analysis of the most frequent TCR from each phenotype/location. Using 
the pooled TCR dataset described in Fig 2.1, we chose the most frequent TCR of a given 
phenotype (shown at left) at each location (shown on top). To decrease the effect of 
mouse-to-mouse variability, we chose only TCRs that were found in at least two 
independent experiments. Because the naïve CD44lo TCRs were fairly uniform across all 
locations, the three most frequent TCRs irrespective of location are shown. Symbols 
represent the frequency (as a percentage of total sequences) of the TCR, denoted above 
by its CDR3 amino acid sequence, within the dataset of that phenotype and the location 
in each of four experiments. 
AASDGNNRIF AASELYQGGRALI AAEPNYNVLY
AASAGTGGYKVVAARDHNYAQGLT AASDGGSGNKLI
AASETGANTGKLTAASEDNNNAPRAASATGANTGKLT
Fo
xp
3+
C
D
44
hi
C
D
44
lo
Spleen Mesenteric LN Inguinal LN
Sp
l
M
es
C
er
v
Ax
il
In
g
0
3
9
6
0
3
9
6
0
3
9
6
12
0
8
4
12
0
4
2
8
6
0
10
5
20
15
0
2
6
4
0
2
6
4
0
2
4
Sp
l
M
es
C
er
v
Ax
il
In
g
Sp
l
M
es
C
er
v
Ax
il
In
g
Figure 2.2 Analysis of the most frequent TCR from each
phenotype/location
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Figure 2.3  The natural Treg and memory CD44hi TCR repertoires vary by 
anatomical location. (A) Anatomical distribution of the most abundant TCR sequences 
within each phenotype. Using the pooled TCR datasets from all four experiments, the top 
50 TCR sequences by frequency within a given phenotype were selected. For each TCR, 
the relative frequency with which it is found at each anatomical location was calculated 
by dividing its frequency at each location by the sum of the frequencies at all locations. 
The frequency is represented on the heat map by decile, with the scale indicating the 
color at 100 (red), 75, 50, 25, and 0% (yellow) for a TCR at a given location. The data are 
clustered such that those TCRs predominantly found in one location are shown together. 
(B) Statistical analysis of similarity. The mean Morisita-Horn similarity index (±SD;n=3-
4 independent experiments) is shown for the comparison betweenthe mesenteric (Mes) 
LNs versus the spleen, cervical (Cerv), axillary (Axil) and inguinal (Ing) LNs (left), and 
the inguinal LNs versus the spleen, Mes, Cerv, and Axil LNs (right). 
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Figure 2.3 The natural Treg and memory CD44hi TCR repertoires vary
by anatomical location.
-48-
-49- 
similarity between two populations, the Morisita-Horn index (Fig. 2.3B, see Materials 
and Methods). By contrast, naïve CD44lo T cells showed little skewing of their TCR 
repertoire by anatomic location, consistent with the notion that these cells circulate 
among the secondary lymphoid organs scanning for foreign antigens.  Thus, these data 
provide direct evidence that the peripheral Treg cell population is shaped by local antigen 
presentation. 
 Interestingly, the CD44hiFoxp3– TCR repertoire behaves much like the Foxp3+ TCR 
repertoire with respect to repertoire changes based on location (Fig. 2.2, 2.3).  For 
example, we observed that in both subsets the TCR usage in the mesenteric lymph nodes 
was very different from that in the other lymph nodes, whereas the inguinal and axillary 
lymph nodes were much more similar to each other (Fig. 2.3B).  This shared pattern of 
TCR localization by the Treg and CD44hi subsets may reflect common recirculation 
patterns and spectra of antigens in these lymph nodes. For example, one might expect the 
axillary and inguinal lymph nodes to share a similar antigenic repertoire since they both 
drain the skin and limbs. We also found, using generalized linear model testing, that of 
the 15 most prevalent Treg and CD44hi TCRs, 10 Treg and 12 CD44hi TCRs showed a 
statistically significant level of skewing according to location (p < 0.05 with Bonferonni 
correction, see Materials and Methods), whereas only 1 of the top 15 naïve TCRs did so 
(Table 2.1).  These data therefore suggest that the peripheral Treg population is shaped 
via a mechanism which is reminiscent of the generation and maintenance of memory 
cells. 
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Distribution of top 15 TCRs from each phenotype. The 15 most prevalent TCRα sequences
found in the Treg, CD44hi, and CD44lo T cell populations in the data pooled from all four
experiments are shown in order of decreasing counts within each phenotype. The number of
instances is the total count for each TCR in the pooled dataset. Red TCR sequences
showed statistically significant differences in their prevalence at different locations based on
the generalized linear model testing described in Materials and methods. We considered the
Bonferroni adjusted p-value (second column from the left) significant if it was <0.05. Of note,
cell purification typically results in the contamination of minor populations (Treg and CD44hi
cells) by the major population (naive cells), with the reverse occurring to a much lower
degree. A 95–98% purity of the Foxp3+ population generally means that 1 out of 20–50 cells
are naive cells, which creates a small degree of false overlap.
Table 2.1 Distribution of Top TCR from Foxp3+, CD44hi and CD44lo Populations
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The Treg and antigen-experienced CD44hi TCR repertoires are distinct.   
 One possible explanation for the observed similarity in the pattern of localization 
between the Treg and CD44hi TCR repertoires is that these cells may co-develop from 
common precursors.  This would be consistent with the hypothesis that peripheral Treg 
cells normally develop during the course of an immune response to limit pathology [45], 
and the observation in TCRαβ transgenic models that peripheral conversion only occurs 
in a portion of antigen-specific T cells after antigen administration [39, 41, 162].  Thus, it 
is quite possible that TCRs which select for development into the antigen-experienced 
CD44hi phenotype may also be found within the Treg cell subset, due to peripheral 
conversion, and potentially account for the well-described overlap between the Treg and 
conventional non-Treg TCR repertoires [34, 35, 37].   
 However, analysis of the fractionated conventional T cell subset revealed that the 
prominent TCRs in the CD44hi subset were not preferentially found in the Foxp3+ subset 
(Fig. 2.4, 2.5).  As expected, the naïve TCR repertoire showed little similarity with either 
of the CD44hi and Foxp3+ TCR repertoires, indicating differential requirements in TCR 
specificity for the development of these CD4+ T cell subsets.  These differences between 
cellular phenotypes were also readily apparent in analyses of the TCRs present in each 
individual experiment, even though the TCR repertoires varied between experiments 
somewhat, particularly for the CD44hi population (Fig. 2.6).  Thus, in these unimmunized 
adult animals, we found little evidence to support the hypothesis that peripheral Foxp3+ T 
cell generation is a prevalent occurrence upon antigen encounter.   
 The strong difference between the TCR repertoires of these three phenotypes is 
further demonstrated by the cluster analysis of a matrix of Morisita-Horn similarity  
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Figure 2.4  Frequencies of the top TCR from the Foxp3+, CD44hi, and CD44lo 
populations. The three most frequent TCRα sequences from each phenotype were 
selected, and their frequency within each phenotype in each experiment was plotted. 
Different symbols represent each of the four experiments. Each TCR tends to be 
prominent in only one of the three phenotypes, as would be expected from the overall 
dissimilarity. 
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Figure 2.4 Frequencies of the top TCR from the Foxp3+, CD44hi, and CD44lo
populations.
-53-
-54- 
 
 
 
 
 
 
 
Figure 2.5  The CD44hi, CD44lo, and Foxp3+ Treg repertoires show little overlap. 
Comparison of the frequencies of prevalent TCRs between the CD44hi and Foxp3+ or 
CD44lo datasets.  In each graph, the 50 most abundant TCRs from each of the two 
indicated populations were selected and plotted on the x axis, with the frequency of the 
TCR in the indicated subset on the y axis. TCRs are arranged in order of decreasing 
frequency within the CD44hi subset, and increasing frequency for the Foxp3+ (top) or 
CD44lo (middle) subset, or decreasing frequency within the Foxp3+ subset and increasing 
frequency for the CD44lo subset (bottom). 
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Figure 2.5 The CD44hi, CD44lo, and Foxp3+ Treg repertoires show little overlap.
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Figure 2.6  Statistical analysis of similarity between different populations. (A) The 
Morisita-Horn similarity values between the indicated phenotypes within each 
experiment (left) and between populations with the same phenotype across different 
experiments (right). (B) Same comparisons as in A, using datasets obtained from three 
individual animals, showing mouse-to-mouse variability. 
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Figure 2.6  Statistical analysis of similarity between different populations.
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indices, which includes comparisons based on both location and cell phenotype (Fig. 2.7). 
This plot reveals the dominant effect of the cell type over the location when all data are 
considered, as the calculated similarities cluster in 5x5 blocks according to cell 
phenotype first.  This analysis also reaffirms the similarity in the naïve T cell repertoires 
between locations, as shown by the uniformly red 5x5 block representing the naïve subset 
repertoires, while the other blocks show relatively high similarity between the axillary 
and inguinal lymph nodes. Thus, these data demonstrate that even though Treg and 
CD44hi cells share a common behavioral feature at the population level, it is unlikely that 
they are generated via a common developmental pathway. 
 
A minor role for peripheral conversion in generating the adult Treg cell population.  
 One explanation for the unexpected lack of similarity between the Treg and antigen-
experienced subset is that peripheral conversion is an infrequent process in unimmunized 
adult animals. Current estimates of the magnitude of peripheral conversion in adult 
animals are quite divergent. One study suggested that many peripheral Treg cells could 
arise via conversion, as approximately 8% of CD25– T cells became CD25+ after transfer 
into a congenic, non-lymphopenic host [43]. If one extrapolates the behavior of the 
adoptively transferred population in this study to represent that of the normal non-Treg 
cell subset at large, conversion would account for approximately 72% of peripheral Treg 
(see Materials and Methods). On the other hand, it has also been suggested that 
conversion occurs infrequently based on a study of monoclonal T cells reactive to an islet 
self-antigen [35]. 
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Figure 2.7  Cluster analysis of the total peripheral TCR dataset. Data shown are a 
heatmap representation of the Morisita-Horn similarity indices calculated pairwise for all 
cell phenotype and location combinations using the pooled TCR dataset. Each decile is 
represented by distinct shades, with the scale indicating the color at 0, 0.5, and 1. The 
mean linkage algorithm was used to obtain a hierarchical cluster (or dendrogram; right) 
by sequentially grouping the two most correlated observations on the basis of a distance 
metric provided by the square root of 1 (Morisita-Horn index). 
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Figure 2.7 Cluster analysis of the total peripheral TCR dataset
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 To measure the potential for peripheral conversion in a polyclonal T cell population, 
we used fluorescence activated cell sorting (FACS) to obtain a highly pure population of 
Foxp3–CD4+ donor T cells from Foxp3gfp mice. We achieved a purity of > 99.998%, or 
less than 1 contaminating Foxp3+ cell per 50,000 Foxp3– CD4+ cells (data not shown). 
Since Treg cells have been reported to divide at a faster rate than non-Treg cells [166], 
we also measured the projected expansion of these few contaminating natural Treg cells 
in this environment by adding approximately 0.001% (100-200 cells per 107) FACS-
purified CD45.1+ Foxp3+ cells to the donor cell population. In order to detect sufficient 
numbers of donor cells by flow cytometry 3-4 weeks after intravenous transfer, we 
analyzed nearly the entire T cell population from the pooled lymph nodes and spleen of 
each recipient.  
 We found that the percentage of donor-derived cells that were Foxp3+ by three weeks 
after transfer was quite low–approximately 0.3% of the donor cells analyzed (Fig. 2.8A). 
Consistent with previous studies, these cells appeared phenotypically similar to natural 
Treg cells (CD25hiGITRhi, not depicted). As the contribution from contaminating Foxp3+ 
donor cells to the final Foxp3+ population was estimated to be about 2%, via analysis of 
the co-injected CD45.1+ cells, we believe that this frequency (0.3%) approximates the 
extent of conversion from peripheral Foxp3– CD4+ T cells. 
 Recent studies have suggested that the gut environment may preferentially facilitate 
peripheral conversion [44, 124, 130]. We repeated the experiment described above to 
compare the frequency of converted Foxp3+ cells in the mesenteric LN, spleen, and the 
pooled cervical, axillary, and inguinal LN. In order to observe sufficient conversion 
events by flow cytometry, each experiment consisted of tissues pooled from three  
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Figure 2.8  Peripheral conversion in nonlymphopenic hosts is infrequent. (A) 
Adoptive transfer of peripheral Foxp3–CD45.2+ (107) and Foxp3+CD45.1+ (1-2 x 102) T 
cells were intravenously transferred into normal Thy1.1 hosts. After 3-4 wk, acquisition 
of Foxp3 was analyzed by flow cytometry. Pooled spleen and LN cells were gated on 
CD4+ and Thy1.2+ (donor cells; left) to determine the frequency of Foxp3+ cells (middle). 
Within the Foxp3+ cells, the outgrowth of the contaminating cells in the original 
CD45.2+Foxp3– population was estimated by the spike of Foxp3+CD45.1+ cells (right). 
Data shown are representative of three independent experiments (n=5 mice), and 
percentages are shown. (B) The frequency of conversion varies by anatomical location. 
The experiment was performed as in A, and after 4 wk the LNs or spleens from three 
animals were pooled for analysis. Data shown are representative of two independent 
experiments, and percentage are shown. (C) Summary of the flow cytometric data 
described in A and B. The frequency of Foxp3+ cells is shown. Each symbol represents 
data from an individual mouse (“pooled”; as in A) or an experiment in which cells from 
the organs of three mice were pooled (as in B) from the spleen, Mes LNs, and a pool of 
Cerv/Axil/Ing LNs. 
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Figure 2.8 Peripheral conversion in nonlymphopenic hosts is infrequent.
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individual mice which had received the same preparation of purified donor cells four 
weeks earlier. Consistent with a previous report [44], we found that the mesenteric LN, in 
comparison with the peripheral LN and spleen, contained an approximately two-fold 
higher percentage of converted Foxp3+ cells (Fig. 2.8, B and C). However, converted 
Foxp3+ cells were found in all locations, at frequencies ranging from 0.2-0.5%.  
 Because conversion appears to occur naturally in  lymphoreplete animals, it was 
possible that this process would reduce the number of cells that can undergo conversion 
in the peripheral Foxp3–CD4+ T cell population used. We therefore assessed the 
frequency of conversion in immediate precursors to the peripheral T cell population, 
mature CD4+CD8– (CD4 single-positive [SP]) thymocytes. We purified 
CD62LhiHSAloFoxp3–CD25–CD4SP thymocytes as well as Foxp3–CD4+ peripheral T 
cells to enable direct comparison between these populations. 3 wk after adoptive transfer 
into congenic hosts, we found that, on average, 0.5% of peripheral CD4+ donor cells and 
0.8% of thymocytes became Foxp3+ (Fig. 2.9). If one extrapolates this behavior as 
representative of their respective T cell populations, then peripheral conversion would 
account for the development of 4-7% of peripheral CD4+Foxp3+ T cells in a normal 
mouse (see Materials and methods). Although this is a rough estimate, it suggests that 
peripheral conversion plays a relatively small role in generating the protective Treg cell 
population in adult individuals. 
 
Peripheral conversion in lymphopenic hosts is TCR-specific.   
 The low rate of peripheral conversion in an adult lymphoreplete animal may be 
caused, in part, to inhibition by the existing Treg cell population.  We hypothesized that  
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Figure 2.9 Peripheral conversion of CD4 SP thymocytes vs. CD4+ peripheral T cells. 
Mature HSAloCD62LhiFoxp3–CD25– CD4 SP thymocytes or Foxp3–CD4+ peripheral T 
cells were adoptively transferred into congenic hosts. The frequency of Foxp3+ cells in 
pooled spleen and LN preparations was assessed at 3 wk by flow cytometry. Each symbol 
represents data from an individual recipient from two experiments in which 3.4 x 106 
(closed circles) or 9 x 106 (open circles) cells were injected per mouse. The horizontal 
bars represent the mean values. 
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peripheral conversion may play a greater role in a lymphopenic environment, such as that 
seen in the early ontogeny of the peripheral immune system, which is both lymphopenic 
[167, 168] and Treg cell deficient due to delayed thymic Treg cell export [32, 169]. 
Therefore, we used the adoptive transfer of CD4+Foxp3– T cells from mice containing the 
fixed TCRβ chain into lymphopenic hosts as a model of peripheral conversion, which has 
previously been reported to occur upon the transfer of non-Treg cells into lymphopenic 
hosts [42, 43].  
 Consistent with previously published results, we observed peripheral conversion of 
the highly purified CD4+Foxp3– T cells from TCli TCRβ chain transgenic mice 2.5-3.0 
weeks after intravenous transfer into Tcrb–/– αβ-T cell deficient mice (Fig. 2.10A). The 
converted cells were phenotypically similar to Treg cells, expressing high levels of 
CD103, GITR, and CD25 (data not shown). Since the incidence of Foxp3 induction 
versus subsequent expansion cannot be discriminated, the extent of “peripheral 
conversion” in this system represents the aggregate outcome. Of note, the percentage of 
converted Foxp3+ cells was considerably higher after adoptive transfer into lymphopenic 
(Fig. 2.10A), as compared with non-lymphopenic (Fig. 2.8), hosts, potentially due to the 
empty Treg cell niche available in Tcrb–/– mice. A second difference between the results 
from these two hosts was the relative frequencies of Foxp3+ cells recovered from the 
various lymph nodes. Lymphopenic hosts showed a decreased frequency of Foxp3+ cells 
in the mesenteric relative to other lymph nodes, which may reflect the preferential 
accumulation of effector cells, as the transfer of CD4+ T cells depleted of Treg is known 
to result in colitis [170]. 
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Figure 2.10  Peripheral conversion resulting from transfer of Foxp3–CD4+ T cells 
into lymphopenic hosts. (A) The frequencies of Foxp3+ cells arising from the transferred 
Foxp3– T cells are summarized, with each line representing an independent experiment. 
The open circles represent the mean values (±SEM) from three mice within an 
independent experiment; the closed circles are values from experiments that consisted of 
pooled cells. The dashed line is the percentage of Foxp3+ cells found in 
a normal animal (for comparison). (B) Description of TCRα chain sequence datasets 
obtained from cells sorted 2.5 wk after adoptive transfer of Foxp3– cells into Tcrb–/– 
hosts. The total number of sequences by experiment, location (Crv, cervical; Mes, 
mesenteric; Spl, spleen) and phenotype are shown. 
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Figure 2.10  Peripheral conversion resulting from transfer
of Foxp3–CD4+ T cells into lymphopenic hosts.
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 Initial experiments analyzing TRAV14 TCRα sequences obtained from FACS-
purified Foxp3+ and Foxp3– CD4+ T cells pooled from several recipient Tcrb–/– mice 
hinted at a fair degree of mouse-to-mouse variability (data not shown), similar to that 
seen in the CD44hi T cell subset in normal mice (Fig. 2.6B). We therefore generated a 
database of over 7,000 Foxp3+ and Foxp3– TCR sequences from the cervical lymph 
nodes, mesenteric lymph nodes, and spleens of 6 individual recipient mice from two 
independent experiments (Fig. 2.10B, Table 2.2).  
 Based on studies of monoclonal TCR populations showing that the majority of the 
antigen-specific T cells remain Foxp3– during peripheral conversion [39, 41, 162], we 
were surprised to find relatively little overlap in TCR usage between the converted and 
non-converted T cell subsets (Fig. 2.11A). Most of the prevalent TCRs identified in these 
experiments showed a marked skewing towards either the Foxp3+ (converted) or Foxp3– 
(non-converted) populations, with only a minority (9 of 85) of the TCRs being found 
more or less equally in both populations (Fig 2.11B). We observed considerable 
differences in the TCR repertoires between the individual mice, even though the donor 
cell population was identical within each experiment (Fig. 2.11C right), which was 
suggestive of the preferential expansion of cells with a low precursor frequency. 
However, the level of dissimilarity between the Foxp3+ and Foxp3– cells from each 
animal was equivalent (Fig. 2.11C left). Unlike the repertoires in the normal mice (Fig 
2.2, 2.3) TCRs in these experiments did not display a skewing of TCR usage according to 
location (Table 2.3), possibly due to the empty T cell nice in these lymphopenic animals. 
Although most TCRs were not found in all six individual mice, TCRs recovered from 
multiple animals were reproducibly found in either the converted, or nonconverted  
TCRs isolated after adoptive transfer are listed by their ability to facilitate peripheral conversion
(Conv %) as in Fig 2.11 B. Rare TCRs found at < 0.5% in the posttransfer Foxp3+ and Foxp3–
subsets were excluded. The number of times the TCR was found in the posttransfer and normal
peripheral and thymic TCR datasets is shown. These more abundant TCRs found in our
peripherally converted dataset (Conv > 80%) account for ~5% (302 out of 5,973) of the total
sequences in the normal Treg TCR repertoire. However, the appearance of a number of these
TCRs in the thymic Treg cell subset suggests that the actual contribution of peripheral conversion
may be considerably lower under normal conditions.
Table 2.2 Comparison of the normal dataset with TCRs found after adoptive transfer
of Foxp3– cells into T cell-deficient hosts.
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Figure 2.11 TCR specificity is important for peripheral conversion in lymphopenic 
hosts.  (A) The converted and nonconverted TCR repertoires differ. TCRα chain 
sequences were obtained as described in Materials and methods. The 50 most abundant 
TCRs from each of the converted Foxp3+ and non-converted Foxp3– pooled datasets are 
shown, with the frequency in the indicated subset on the y axis. The TCRs are ordered 
from the most abundant in the Foxp3+ subset (left) to the most abundant in the Foxp3– 
subset (right). (B) TCRs are preferentially skewed toward either the Foxp3+ or Foxp3– 
subset. For prevalent TCRs in the pooled dataset (summed frequencies >0.5%), the 
percentage of each TCR in the Foxp3+ subset (% Foxp3+/% Foxp3+ + Foxp3–) is plotted 
in decreasing order. Arbitrary cutoffs (vertical dashed lines) are shown for TCRs highly 
(> 80% Foxp3+), poorly (< 20%), or not (< 1%) associated with conversion. (C) 
Assessment of mouse-to-mouse variability. (left) Morisita-Horn index values comparing 
the Foxp3+ and Foxp3– TCR datasets within each individual recipient are shown. (right) 
The Foxp3+ TCR datasets from individual animals within the same experiment are 
compared in green, and the Foxp3– datasets are compared in orange. There were four and 
two recipients for the first and second independent experiments, respectively. 
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subsets, with few exceptions (Fig. 2.12). Thus, even though both peripheral conversion 
and lymphopenia-induced proliferation of non-Treg cells occurred within the same 
animal, these data demonstrate that TCR specificity played an important role in Treg cell 
fate determination during this immune response.   
 
TCRs that facilitate peripheral conversion are also found within the normal peripheral 
and thymic Treg TCR repertoire.   
 Although we were unable to determine which TCRs undergo peripheral conversion in 
normal (non-lymphopenic) hosts due to the low rate of conversion, we did identify TCRs 
that facilitate peripheral conversion during the immune response in lymphopenic hosts.  
As would be expected, these converted TCRs are found in the normal non-Treg cell 
subsets, since the donor cells for these studies were normal Foxp3– cells (Fig 2.13A). 
Interestingly, these TCRs were also often found in the normal Treg cell subset, and 
constitute approximately 5% of the sequences in the normal peripheral Treg cell data set 
(Table 2.2).  Although the extent that these TCRs affect the Treg TCR repertoire in 
lymphoreplete individuals by peripheral conversion is unknown, these data support our 
observation that peripheral conversion makes only a small contribution to the normal 
Treg cell population. 
 It has been proposed that peripheral conversion may play an important role in 
generating Treg cells to antigens which are not present in the thymus, such as those found 
in the gut [44, 124, 130]. This would predict, then, that converted TCRs should generally 
be found within the peripheral, but not thymic, Treg cell subset. We found that, of the 
highly converting TCRs that were also present in our thymic sequence data set [164],  
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Figure 2.12  Reproducibility of TCR-dependent conversion. Foxp3–CD4+ cells were 
transferred into αβ T cell–deficient hosts and recovered 2.5 wk later for TCR sequencing 
(Figs. 2.10, 2.11). TCRs that were identified at a frequency of >1% in two or more 
recipients were selected, and the frequencies of the indicated TCR in each of the six 
individual mice are shown. The frequencies within the Foxp3+ (converted) population 
(green) are shown above the axis, and the frequencies within the Foxp3– (nonconverted) 
population (orange) are shown below the axis. Ms, mouse. 
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Figure 2.13 TCRs that facilitate peripheral conversion are found in the normal 
peripheral and thymic Treg cell TCR repertoires.  (A) Comparison with the normal 
peripheral TCR repertoire. Prevalent TCRs recovered after the transfer of Foxp3– cells 
into lymphopenic hosts that are also found in the normal peripheral dataset (Fig 2.1) at a 
summed frequency of > 0.15% were identified (Table 2.3). The frequencies of these 
overlapping TCRs in the normal dataset are plotted. The TCRs are sorted by their ability 
to facilitate conversion, as designated by the vertical dashed lines on Fig. 2.12. (B) 
Comparison with the normal thymic TCR repertoire. The frequency of the TCR in the 
normal thymic dataset [164] is shown as in A.  
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most (11 of 12) could be found within the Foxp3+ subset (Fig. 2.13B). By comparison, 
only 2 of 11 TCRs from the poorly converting category were found within the thymic  
Foxp3+ data set. One potential explanation for this observation is the presence of 
recirculating mature peripheral CD4+Foxp3+ T cells in the thymus. Although the 
frequency of recirculating T cells appears low by previous reports [171, 172], a direct 
assessment of Foxp3+ Treg cell circulation in normal hosts was not performed. To test 
this possibility, we injected 20 x 106 enriched peripheral CD4+ T cells into a congenic 
host and assessed the percentage of donor cells in the CD4SP thymocyte population after 
1 week (Fig. 2.14). If one assumes that the behavior of the donor cells is representative of 
all peripheral CD4+ T cells, then about 4% of thymic Treg cells arise from recirculation. 
Because these shared TCRs are not grossly overrepresented in the periphery compared 
with the thymus, recirculation alone is unlikely to account for the thymic observation of 
TCRs that facilitate peripheral conversion. Rather, we favor the hypothesis that some 
TCRs are able to facilitate both thymic and peripheral Treg development. Because we 
expect primarily self-antigens to be presented in a normal thymus, these data suggest that 
some self-reactive cells, upon escaping Treg cells selection in the thymus, may get a 
“second chance” to become Foxp3+ regulatory cells via peripheral conversion. 
 
TCR specificity plays a crucial role in peripheral conversion.  
 The observation that many TCRs found preferentially on converted Treg cells are also 
found on normal thymic Treg cells raised the possibility that we were merely observing 
Foxp3 induction in Foxp3– Treg cell precursors that arise in the thymus, and are then 
exported before Foxp3 is expressed [173].  We therefore asked whether TCR specificity 
-81- 
Figure 2.14 Recirculation of peripheral CD4+ T cells to the thymus. 20 million CD4+ 
T cell–enriched spleen and lymph node cells were injected into normal congenic 
recipients. 1 wk later, the spleen and thymus were analyzed by flow cytometry to 
determine the percentage of CD4+ T cells derived from the donor (left), and the 
percentage of those that are Foxp3+ (right). Data are pooled from two independent 
experiments (n = 5 mice), summarized in the bottom graphs (closed circle, individual 
mouse; horizontal line, mean). To estimate the percentage of thymic T reg cells that come 
from recirculating peripheral T cells, we assumed that the behavior of our adoptively 
transferred CD4+ cells represented that of the normal peripheral T cell population. 
Therefore, recirculating cells comprise ~0.8% of the CD4 SP population (0.03% of donor 
T cells in the CD4 SP thymus times 26.3, the ratio of host:donor cells in the spleen 
[1:0.038]). 16.4% of recirculating cells are Foxp3+; this suggests that recirculating Treg 
cells comprise 0.13% of the CD4 SP population. Thus, ~4% of the normal thymic Treg 
cell subset may arise from recirculation (0.13% of  ~3%, the normal thymic Treg cell 
frequency). If we assume that Treg cells that develop in the periphery recirculate as 
estimated, then the extent of thymic recirculation is not sufficient to account for the 
presence of thymic Treg cells with TCRs also found in the converted population. For 
example, two of the most frequent TCRs found within the converted Foxp3+ population, 
with CDR3 amino acid sequences AASDYGSSGNKLI and AASANSGTYQR (Table 
2.2), are found in the normal Treg cell population at frequencies of 0.8 and 0.4%, 
respectively. Therefore, we could expect that they would account for 0.032% (0.8 x 4%) 
and 0.016% (0.4 x 4%) of thymic T reg cells. However, their frequencies within the 
normal thymic Foxp3+ population are far greater (0.4 and 0.3%, respectively). 
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alone, in the absence of thymic conditioning, is sufficient to direct peripheral conversion 
by introducing selected TCRα chains into peripheral monoclonal T cells from TCli αβ- 
TCR transgenic x Foxp3gfp mice on a Rag1–/– background and then transferring them into 
Tcrb–/– hosts [33].  As the cells were isolated and treated identically, they should differ 
only by the additional retroviral TCRα chain at the time of transfer.   
 We first tested two TCRα chains (B2, B132) that were previously identified in naïve 
T cells, and also found primarily in the non-converted T cell subset in our lymphopenic 
expansion experiments (Fig. 2.15 A). These TCRs were also previously shown to be 
unable to facilitate in vivo expansion of T cells in Rag1–/– hosts [37]. Consistent with 
their low frequencies in the converted TCR data sets, we found that these naïve TCRs did 
not facilitate either Foxp3 induction or expansion (Fig. 2.15 B).  Therefore, TCR 
activation and retroviral introduction of an additional TCRα chain alone are not sufficient 
to induce Foxp3 expression in these cells. 
 We then tested four TCRα chains that were identified in the highly converting 
Foxp3+ TCR data set (R19, R22, TR3, and TR5; Fig. 2.15 A, Table 2.2), and found that 
they also facilitated peripheral conversion in retrovirally transduced cells (Fig. 2.15 B, 
top). Thus, these data demonstrate that TCR specificity alone, in the absence of a unique 
thymic signal, is sufficient to facilitate the process of peripheral conversion.  
 Because these highly converting TCRs were also found in the normal Treg TCR data 
set, we tested the ability of other natural Treg TCRs that were not found in the conversion 
experiments to facilitate conversion. Interestingly, only one of the four Treg TCRs tested 
(R111) was able to induce Foxp3 in a sizable proportion of cells, whereas the others did 
not (G113, G5, G57). The inability to augment conversion was presumably not due to a 
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lack of TCR engagement, as these other TCRs did facilitate in vivo expansion (Fig. 2.15 
B, bottom), suggesting that their cognate antigens were available in the periphery. It also 
appeared that certain TCRs favored expansion and conversion in different anatomic 
lymph nodes, which is consistent with our analysis of the normal Treg TCR repertoire 
(Fig. 2.2, 2.3). For example, R22 seems to promote conversion in the axillary and 
inguinal LNs, but less so in the mesenteric LNs (Fig. 2.15 B, top). Conversely, G57 
showed expansion in the mesenteric LN but not in the axillary and inguinal LNs, (Fig. 
2.15 B bottom), in accordance its distribution in the normal Treg cell population.  In 
summary, these data suggest that TCR specificity determines whether a cell is capable of 
peripheral conversion, but that not all TCR specificities associated with peripheral Treg 
cells have this capability.  
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Figure 2.15  TCR specificity is sufficient to direct peripheral conversion in 
lymphopenic hosts.  (A) Frequency distribution of TCRs tested. Data shown are the 
frequencies (percentages) of the TCRs in the datasets from thymocytes, normal peripheral 
T cells, and T cells recovered after adoptive transfer into lymphopenic hosts. (B) 
Retroviral manipulation of TCR specificity in peripheral T cells. Monoclonal TCli 
αβTCR transgenic T cells were transduced with TCRα chains, as described in Materials 
and methods. (top) The frequency of Foxp3+ cells in the transduced (Vα2+Vβ6+CD4+) T 
cell population was assessed by flow cytometry 2.5 – 3 wk after adoptive transfer into 
Tcrb–/– mice. (bottom) The absolute number of transduced (Vα2+) cells recovered was 
calculated using the total cell count and the frequency of Vα2+Vβ6+CD4+ T cells within 
the live gate, as determined by flow cytometry. Data shown are from individual mice and 
were obtained from five independent experiments constituting at least two independent 
retroviral transductions per TCR. Each symbol represents data from an individual 
recipient (n = 4-6), and the horizontal bars represent mean values. 
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Figure 2.15 TCRs that facilitate peripheral conversion are found in
the normal peripheral and thymic Treg cell TCR repertoires
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Chapter 2: Discussion 
 Our analysis of the peripheral TRAV14 TCR repertoire strongly suggests that 
immune regulation is a tissue-specific activity, as the antigen-specificity of the protective 
Treg cell population changes considerably by anatomic location (Fig. 2.2, 2.3).  These 
data are consistent with our previous observations of individual Treg TCR-driven 
proliferation in normal hosts, in which CFSE dilution was more pronounced in certain 
lymph nodes [33].  Thus, the observation that tissue-specific antigens greatly modify the 
local Treg TCR repertoire provides direct evidence for a mechanism by which the 
presence of an organ facilitates Treg cell-mediated tolerance to that organ [78-80].  
 Another intriguing observation is that the Treg and CD44hi TCR repertoires showed 
similar patterns of variability by anatomic location.  This suggests that Treg and CD44hi 
populations share similar fundamental behaviors governing their interaction with tissue-
specific antigens, even though the conditions for their development may be different.  
These data therefore support previous studies using monoclonal TCR transgenic mice 
[174] demonstrating that both Treg and non-Treg cells undergo clonal expansion upon 
antigen encounter.  The expansion and maintenance of Treg cells specific for antigens 
normally presented in the peripheral self would favor tolerogenic Treg cell responses to 
those antigens, rather than novel foreign antigens.  Thus, we hypothesize that shaping of 
the Treg cell population to the local antigenic landscape provides another mechanism for 
self/non-self discrimination by the immune system.   
 Contrary to previous studies [43], we did not find that peripheral conversion played a 
prominent role in the generation of the peripheral Treg cell population (Fig. 2.8). This 
difference could be explained in part by our use of Foxp3 as a marker for Treg cells, 
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rather than CD25 [32], to isolate non-Treg cells for adoptive transfer and analysis of 
conversion. Nonetheless, the use of mature Foxp3–CD4+ thymocytes may still 
overestimate the role of peripheral conversion because we cannot exclude the presence of 
rare CD25–Foxp3– Treg cell precursors within this subset. We can also not be certain that 
these mature thymocytes are phenotypically identical to recent thymic emigrants in terms 
of their potential to undergo peripheral conversion. On the other hand, the use of 
peripheral Foxp3–CD4+ T cells may underestimate the role of peripheral conversion 
because we can only assess the fraction of Foxp3– cells capable of converting at steady 
state, and those T cells with the greatest propensity to undergo peripheral conversion are 
likely to be underrepresented.  Thus, we believe our estimate that peripheral conversion 
contributes about 4-7% of the normal adult peripheral T reg cell population represents the 
best currently available figure. 
 We also studied the process of peripheral conversion during the immune response of 
Foxp3– cells transferred into αβ-T cell deficient hosts, which may mimic the 
lymphopenic and Treg cell-deficient conditions during the early neonatal period.  We 
found that peripheral conversion occurred much more readily in this environment than in 
a lymphoreplete host, and this made it technically feasible to perform TCR usage 
analysis.  Interestingly, we found that peripheral conversion in polyclonal populations did 
not mirror previous experiments using monoclonal T cell populations, where a portion (~ 
20%) of cells became Foxp3+ after non-inflammatory antigen encounter in both non-
lymphopenic and lymphopenic models [39, 40, 173].  Rather, we observed no consistent 
patterns governing peripheral conversion during T cell expansion, finding that individual 
TCRs ranged from being highly skewed toward or against peripheral Treg cell 
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development (Fig. 2.11B, 2.12).  Thus, the analysis of polyclonal TCR repertoires from 
both lymphopenic and non-lymphopenic environments do not support a model in which 
peripheral conversion is an automatic consequence of T cell activation, but rather one in 
which peripheral conversion is highly dependent on TCR specificity. 
 Although our data do not directly allow us to determine whether peripheral 
conversion occurs upon recognition of non-self antigens, it appears likely that many 
TCRs which facilitate conversion are reactive to self antigens. This is strictly based on 
the observation that several TCRs from converted Treg cells in lymphopenic hosts can 
also be found in the normal thymic Treg cell subset (Fig. 2.13, Table 2.2). As previously 
argued, we believe that thymic Treg development occurs via recognition of self [164], 
rather than nonself [81], antigens. Although we cannot exclude the possibility of 
peripheral nonself-antigen presentation in the thymus, nor the possibility that different 
peptides are recognized in the thymus and periphery, the most straightforward 
explanation is that the same self-reactivity that induces Treg cell development in the 
thymus also does so in the periphery. Although future experiments will be required to 
prove that the observed bias of converted TCRs toward the thymic Treg TCR repertoire is 
caused by the recognition of the same self-antigens, these data suggest that some cells 
that escape thymic Treg cell development express self-reactive TCRs which facilitate a 
second chance for Treg cell development in the periphery. 
 Peripherally converted Treg cells may develop directly from naïve T cells, or instead 
differentiate from memory/effector T cells [173]. In vivo data suggests that an 
appreciable frequency of Foxp3+ cells requires one or more weeks to develop [39-41]. 
This time frame favors a multi-step process, but may also reflect a need for post-
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conversion expansion. By contrast, in vitro studies have suggested that TGFβ−mediated 
induction of Foxp3 is considerably more efficient in naïve than memory T cells [175]. In 
fact, it has been reported that TGFβ is unable to induce Foxp3 in previously in vitro 
differentiated T cells [176]. Because in vitro TCR stimulation is used in the retroviral 
transduction protocol, our data directly demonstrate that, in vivo, peripheral conversion 
from previously activated T cells can still occur in the context of an appropriate TCR 
specificity (Fig. 2.15), hinting at possible differences between in vitro and in vivo 
conversion. 
 It is clear, however, that conversion alone is insufficient to maintain immune 
homeostasis, as shown by the development of colitis and other autoimmune 
manifestations upon transfer of Treg cell-depleted CD4+ T cells [78-80, 152, 170].  
However, conversion may diminish the severity of disease [41, 177].  The inability to 
prevent disease may be due to the limited Treg TCR repertoire generated by peripheral 
Treg cell development, which has been suggested to permit autoimmunity in 
lymphopenic mice [178]. Alternatively, it may be that peripheral conversion occurs too 
late to fully prevent autoimmune pathology. One interesting hypothesis is that 
autoimmune disease may also be exacerbated by self-reactive Foxp3– T cells expressing 
Treg TCRs that escape into the periphery [33],  but are unable to undergo peripheral 
conversion due to their antigen specificity (Fig. 2.15). 
 These data demonstrate a critical role for TCR specificity in the decision to undergo 
peripheral conversion. One potential mechanism by which this occurs is that the “nature” 
of the TCR-ligand interaction itself could generate a unique signal that results in Foxp3 
expression. This has been suggested by an αβ-TCR x cognate antigen double transgenic 
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model of thymic Treg cell development [36]. In this model, the high affinity ligand 
induced both deletion and Treg cell development, whereas a slightly different, lower 
affinity ligand could only induce deletion. However, a mechanism dependent on unique 
TCR signals would be unable to distinguish the context of T cell activation in the 
periphery, making it teleologically less appealing. An alternative, non-mutually 
exclusive, hypothesis is that the TCR specificity results in activation within an 
environment which facilitates peripheral Treg cell development. We favor this latter 
model, in which antigen presentation can occur on APCs and/or within 
microenvironments that determine whether a given T cell will become a regulatory or 
effector cell. Based on current data, we suspect that a microenvironment promoting 
peripheral conversion would contain TGF-β and potentially retinoic acid [40, 44, 124, 
130]. Therefore, the balance of antigen presentation between two different 
microenvironments would determine the pathologic or tolerogenic outcome of the 
immune response to an antigen. 
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The Colonic Foxp3+ Regulatory T Cell Repertoire is Shaped by 
Recognition of Commensal Gut Bacteria 
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Chapter Three: Preface 
 The findings described in this chapter were a natural outgrowth of the results 
described in Chapter Two. In sequencing TCRs from CD4+ T cells in various locations, 
we wondered if those found in the gut would show signs of antigen specificity and a 
unique TCR repertoire. In the gut, this would imply that at least a portion of the Treg 
cells would have developed extra-thymically, via peripheral conversion, in response to 
unique antigens derived from the commensal microbiota, which would not be available 
for selection in the thymus.  With reports such as that by Sun et. al. [44] showing an 
increased prevalence of conversion in the GALT, and our own finding that conversion 
was higher in the MLN than in other LN or the spleen [150], we expected we might see 
more evidence of peripheral conversion in the Treg of the gut.  
 The large portion of these studies included in this chapter would not have been 
possible without the generous and enthusiastic contribution made by our collaborators 
Seth Bloom and his mentor Thad Stappenbeck. Seth’s offer of his knowledge and skills 
to culture many strains of bacteria that live in the colon and cecum of the mice in our 
colony made possible some of the most exciting results we present in this chapter, and for 
this I am greatly indebted to him. He has contributed to the Materials and methods 
section of this chapter directly with a description of his techniques in culturing bacteria 
from the intestinal contents. The studies presented here are currently being prepared as a 
manuscript for publication. 
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Chapter Three: Abstract 
 Regulatory T cells (Treg) play an essential role in the maintenance of homeostasis 
in the face of constant exposure to the organisms, both beneficial and potentially harmful, 
which are encountered in the gut. To determine if the colon, with its unique environment 
and antigens derived from the commensal microbiota, harbors an equally unique Treg 
population we determined the repertoire of TRAV14 (Vα2) TCRα chains found on the 
CD4+Foxp3+ T cells of the spleen, mesenteric lymph nodes (LN), cervical LN, and 
colonic/cecal lamina propria (LP) in mice expressing a single TCRβ chain. We found the 
repertoire of the colon Treg to be unique, with no appreciable overlap with Treg from 
other locations in the body, nor with the naïve or CD44hi memory T cells in the colon. 
Using reporter hybridomas expressing those TCRs found most commonly on the colonic 
Treg, we screened for reactivity to preparations of bacteria cultured from the colon and 
cecum of mice in our colony. Amazingly, 3 of 12 TCRs tested were found to react to 
specific bacterial preps, and 4 others reacted to a preparation of autoclaved colon/cecal 
contents. CD4 single-positive (SP) thymocytes expressing these TCRs showed no sign of 
Foxp3 expression in the thymus, while those expressing Treg TCRs from other locations 
did. T cells expressing two of these bacterial-reactive TCRs were confirmed to show no 
Foxp3 expression in the thymus in mixed bone marrow chimeras. However, these T cells 
developed Foxp3+ T cells in the colonic LP when hosts were cohoused with littermates of 
the mice expressing the fixed TCRβ chain. These studies show that the colonic Foxp3+ 
Treg show unique TCR specificities, some of which develop in situ upon recognition of 
antigens derived from commensal bacteria. 
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Chapter Three: Introduction 
 The maintenance of tolerance in the gut requires that the immune system retain 
the ability to respond to pathogens but also be tolerant to the large number of 
microorganisms which inhabit the site, many of which provide essential nutrients and 
other benefits to their host. When this ability to maintain tolerance to the commensal 
microbiota fails, the result is inflammatory bowel disease (IBD), which in humans 
generally manifests as Crohn’s disease or ulcerative colitis. These debilitating and 
sometimes fatal diseases affect an estimated 0.1 – 0.2% of the population [133]. 
 One important part of the strategy employed by the immune system for 
accomplishing this feat are the CD4+Foxp3+ regulatory T cells (Treg). These cells are 
essential for the maintenance of gut homeostasis. In Foxp3-deficient scurfy mice, and in 
patients harboring a mutation in Foxp3, one of the earliest autoimmune manifestations to 
occur is severe enteropathy [144, 179]. Similarly, in mice engineered to express the 
human diptheria toxin (DT) receptor under the Foxp3 promoter, administration of DT 
results in elimination of the Foxp3+ T cells, and severe wasting disease quickly develops 
[30]. A widely used model for the development of IBD is the transfer of T cells depleted 
of the Treg population into a lymphopenic recipient; in the absence of regulation these T 
cells cause intestinal inflammation, which can be prevented by the co-transfer of the 
Foxp3+ Treg population [146]. 
 Most Treg develop their regulatory phenotype, indicted by the expression of 
Foxp3, during thymic selection [33-35, 150]. However, Foxp3+ regulatory cells can also 
develop from mature, non-regulatory CD4+ T cells outside of the thymus under certain 
conditions, a process termed peripheral conversion [173]. This has been shown to occur 
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under circumstances in which cognate antigen is introduced in a non-inflammatory 
setting, and may be a mechanism to generate tolerance to antigens not found in the 
thymus. While it is estimated that peripheral conversion does not contribute greatly to the 
peripheral Treg repertoire [34, 35, 150], several studies have shown an increased amount 
of conversion in the mesenteric LN (MLN) and small intestine lamina propria, under 
steady state conditions and during induction of oral tolerance [44, 124, 150]. However, 
these studies did not address the potential for conversion in the colon.  
 The dendritic cells (DC) found in the gut appear to be uniquely capable of 
mediating peripheral conversion. In particular, the CD103+ DC have been shown to carry 
bacterial antigens from the lamina propria to MLN [91]. DC can obtain bacterial antigens 
that have been transcytosed by M cells in the intestinal epithelium, by the phagocytosis of 
apoptotic intestinal epithelial cells which may have been invaded by bacteria, or even by 
direct sampling of luminal contents [90]. Therefore, it would seem likely that T cells 
recognizing bacterial antigens presented by these tolerogenic intestinal DC may become 
Treg that are then capable of mediating tolerance in the intestines. Exposure to this subset 
of DC also causes upregulation of gut homing molecules, due to their ability to provide 
retinoic acid (RA), and therefore can also cause these T cells to traffick to the LP [123, 
129]. 
 There is some evidence that Treg in the gut need to recognize bacterial antigens to 
efficiently preserve tolerance to the commensal bacteria. Strauch et. al. showed that co-
transfer of CD4+CD62L– cells (containing the regulatory population) isolated from germ 
free mice did not prevent disease development after transfer of CD4+CD62L+ T cells into 
SCID mice [147]. However, it appears from the low expression of GITR and deficiency 
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in Foxp3 mRNA that the germ-free CD4+CD62L– T cells may have been relatively 
deficient in Foxp3+ Treg. Using the transfer of CDRBhi cells into SCID mice, Singh et. 
al. showed that co-transferred CDRBlo cells from germ free mice were capable of 
preventing IBD only at high cell numbers, but when fewer Treg were transferred they 
proved to be less efficient than the comparable population from SPF mice [148]. These 
studies imply that without bacterial recognition, the Treg population in the colon is 
somewhat incomplete. 
 In a previous report we showed that the TCR repertoire of Foxp3+ Treg varied 
according to their location, suggesting that the repertoire is reflective of the local 
antigenic milieu [150]. These TCRs also differed from those found on the activated 
memory T cells expressing high levels of CD44, indicating that these two populations do 
not overlap in their antigen specificity. We speculated that the unique antigenic 
environment of the colon would result in a particularly unique repertoire of TCRs being 
used by the colonic Treg cells, and therefore this led us to sequence the TCRα chains 
from Foxp3+, CD44hi, and naïve CD44lo CD4+ T cells isolated from the colonic LP of 
mice expressing a fixed TCRβ chain. Indeed we found that these TCR were not shared 
with Foxp3+ TCRs found in other locations, nor with the activated/memory CD44hi or 
naïve CD44lo populations.  
 We hypothesized that these unique specificities may be due to the availability of 
antigens derived from the commensal microbiota, and that these Treg may develop from 
Foxp3– cells via peripheral conversion. We indeed found that several of these TCRs 
recognized antigens derived from commensal bacteria or recognized some component of 
the colon/cecum contents of mice in our colony but not from germ-free mice. T cells 
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expressing these TCRs showed no sign of Foxp3 expression in the thymus, but two such 
TCRs were demonstrated to have developed Foxp3 expression after isolation from the 
colonic LP. Therefore, at least some Treg found commonly in the colonic LP have 
developed in the periphery upon recognition of an antigen derived from commensal 
bacteria. 
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Chapter Three: Materials and methods 
Mice 
 The Foxp3gfp reporter knockin, TCliβ transgenic and TCliαβ transgenic mice 
were kindly provided by Dr. Alexander Rudensky (then at the U. of Washington, Seattle, 
WA) and were bred in the specific-pathogen-free (SPF) facility at Washington University 
in St. Louis. Rag1–/– and Tcra–/– mice were obtained from the Jackson Laboratory (Bar 
Harbor, ME). CD45.1 congenic mice were obtained from National Cancer Institute 
(Frederick, MD). Animals were used according to protocols approved by the Institutional 
Animal Care and Use Committee.  
 
Cell purification, sorting and sequencing 
 Colonic lamina propria lymphocytes were isolated from the cecum and colon 
combined, rinsed with cold medium, cut into small pieces and incubated in RPMI 
containing 3% FBS, 20 mM HEPES, 5 mM EDTA and 0.145 mg/ml DTT for 20 
minutes at 37˚C with constant stirring. Pieces then underwent three rounds of shaking in 
RPMI + 2 mM EDTA, followed by digestion of the pieces in 0.2 mg/ml Liberase CI 
(Roche) for 15 minutes at 37˚C with constant stirring, followed by addition of fresh 
enzyme and stirring for another 15 min. Digested tissue was forced through a Cellector 
tissue sieve (Bellco Glass, Inc.) and then underwent washing and filtering through 70 µm 
and 40 µm filters. Cells were spun down and resuspended in 2ml of RPMI containing 
10% FBS, filtered through a 37 µm filter, counted and then stained with antibodies and 
either analyzed or sorted by flow cytometry as described below.  
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 T cell suspensions from the spleen or lymph nodes to be sorted were incubated 
with biotinylated anti-B220 (RA3-6B2) and anti-CD8 (53-6.7) antibodies (Biolegend), 
followed by incubation with anti-biotin magnetic microbeads (Miltinyi Biotech) and 
enriched by depletion by magnetic separation using an AutoMACS (Miltinyi Biotech). 
Remaining cells were stained with antibodies for CD4 (RM4-S), Vβ6 (RR4-7) and CD44 
(IM7) and sorted by flow cytometry using a FACSAria (Becton Dickinson). Cells to be 
analyzed by flow cytometry were stained with a combination of fluorescently-labeled 
antibodies including: Vβ6 (RR4-7), CD4 (RM4-S), CD8 (53-6.7), Vα2 (B20.1), GITR 
(YGITR 765), CD25 (PC61), Thy1.2 (30-H12), CD45.1 (A20), CD45.2 (I04), and CD24 
(M1/69). 
 Cloning of TRAV14 TCRα sequences from sorted T cells was performed as 
previously described [33]. As before, we utilized the CDR3 amino acid sequence 
provided by IMGT/V-QUEST as a unique identifier for individual TCRs [163]. 
 
Statistical Analysis 
  The Morisita-Horn similarity index was used to assess the amount of similarity 
between any two sets of TCR sequences, as in previous studies [33, 37, 150]. This unit-
less index ranges from 0 to 1, with 0 representing complete dissimilarity and 1 being 
absolutely identical [165]. The Morisita-Horn index takes into account the frequency of 
each TCR, and is relatively resistant to the sample size, as compared with other similarity 
indices such as the Jaccard. A sequence found in both data sets at greatly different 
frequencies would therefore contribute to dissimilarity by this index. For reference, a 
comparison of the first 200 randomly chosen sequences with the last 200 sequences of an 
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~400 sequence data set results in a Morisita-Horn index of about 0.9, which represents an 
experimentally derived value for the maximum expected similarity, incorporating the 
inherent variability due to random sampling.  
 
 
Creation and screening  of hybridoma cell lines expressing colonic Treg TCRs 
 The 58α−β− hybridoma cell line stably transduced with hCD4-pA-GFP-NFAT-
RVT was a generous gift of Wataru Ise in the laboratory of Ken Murphy (Washington 
University in St. Louis) [180]. This hybridoma was then transduced with MigR1-derived 
retrovirus (without IRES GFP) containing TCli TCRβ chain and downstream mCD4 
under an IRES. These hybridomas were sorted for expression of mCD4 and the sorted 
cells used as the parental cell line for introduction of TCRα chains of interest by 
retroviral transduction with MigR1-derived retrovirus containing the TCRα chain. After 
introduction of the TCRα chain, cells were allowed to expand and then sorted for high 
surface expression of the TCR. 
 Dendritic cells (DC) used in these cultures were obtained from a wild type mouse 
injected with 3-5 x 106 B16 melanoma cells engineered to produce Flt3 ligand (Flt3L) 
subcutaneously 7-8 days prior. Spleen and enlarged inguinal LN from the side of 
injection were collected and DC were enriched by use incubation with biotinylated 
CD11c mAb (N418) (Biolegend) followed by incubation with anti-biotin MACS 
microbeads (Miltinyi Biotech) and subsequent positive selection with an AUTOMacs 
(Miltinyi Biotech). Cells were washed, resuspended in DMEM with 10% FBS, and used 
as APC in screening cultures. 
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 1x104 colonic Treg TCR-expressing reporter hybridomas cells were cultured with 
1x104 DC and antigen from either individual bacterial isolates, pools of bacterial isolates, 
medium only, autoclaved cecum/colon contents (ACP, see below), or 0.1 µg/ml αCD3. 
The amount of bacterial prep or ACP added was optimized experimentally; the most that 
could be added without compromising the health of the cells was used. Often this was 
about a 1:200 final dilution in the culture. In some cultures, blocking aMHC class II mAb 
(M5-114) was added at 10 µg/ml. After about 40-44 hours cells were collected and 
stained with CD4 and Vβ6, and analyzed by flow cytometery on a FACSCanto (Becton 
Dickinson). 
  
Creation of bacterial and cecum/colon content preps for screening 
Cecum and colon contents of two mice that were wild-type littermates of the TCli 
TCRβ trasnsgenic mice used for sequencing studies were aseptically harvested under 
anaerobic conditions, pooled in sterile pre-reduced PBS, and plated on a variety of media 
types in serial, half-log dilutions, which allowed isolation of unique-appearing colonies 
from the plates with the largest number of individually distinguishable colonies [181, 
182]. The media types used for anaerobic culture were Anaerobic Reducible Blood Agar 
(ANB) (Remel, general anaerobic growth media), Anaerobic Reducible CNA Blood Agar 
(ACNA)(Remel, enriched for growth of Gram positive anaerobic organisms), Anaerobic 
Reducible LKV Blood Agar (LKV) (Remel, selective for growth of Gram negative 
obligate anaerobes), Bacteroides fragilis Isolation Agar (BBE) (Remel, contains 
gentamicin to inhibit most facultative anaerobes, bile to inhibit most anaerobic gram 
negative bacteria, and esculin to differentiate members of the B. fragilis group), and 
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Rogosa agar (Rog)(for cultivation of lactobacilli). The media types used for aerobic 
culture were Tryptic Soy Agar with 5% Sheep Blood (TSA) (Remel, general aerobic 
growth media), Chocolate Agar (Choc) (Remel, general aerobic growth media enriched 
for isolation of fastidious aerobes), Columbia CNA with 5% Sheep Blood (CCNA) 
(Remel, for selective isolation of gram-positive cocci and inhibition of gram-negative 
bacilli), and MacConkey Agar (Mac) (selective and differential for isolation of gram 
negative aerobes or facultative anaerobes).  
Cultures were incubated for 2-7 days at 37°C in ambient room air (aerobic 
cultures) or 7-14 days in a Bactron-IV Anaerobic Chamber (Shel Lab) at ~37°C in an 
atmosphere of 5% hydrogen, 5% carbon dioxide, and 90% nitrogen (anaerobic growth). 
Unique-appearing single colonies were picked and sub-cultured them on fresh media, 
then passaged a second time to ensure purity. Sub-cultured bacteria were subsequently 
grown in BHI broth or Thioglycollate broth (Remel), concentrated by centrifugation, re-
suspended in sterile PBS, and concentrated again by centrifugation. Cultures that did not 
grow in liquid media were removed from the surface of culture plates using sterile swabs 
and resuspended in sterile PBS. Aliquots were frozen for subsequent re-culture and for 
DNA isolation. The remainder was heat-killed by incubating at 75°C for 60 minutes, then 
frozen and preserved for subsequent T-cell analysis. 
 To prepare whole colon and cecal contents for screening (ACP) the contents were 
collected and mixed with PBS to make a slurry which was homogenized using a VWR 
PowerMAX homogenizer. The preparation was then autoclaved to sterilize, and filtered 
through sterile 70 µm nytex mesh to remove large particulates. The preparations were 
then frozen at –20˚C for short-term use or –80˚C for long term use. 
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Identification of bacterial isolates using 16S rRNA sequencing  
 Genomic DNA was extracted from individual isolates and the bacterial 16S rRNA 
gene was PCR-amplified using primers Bact-8f and Bact-1510r [84, 183]. The resulting 
PCR product was then sequenced using one or both of the original PCR primers. 
Sequences were edited and trimmed for quality using the Trev 1.9 program of the Staden 
Package©. When available, forward and reverse reads were assembled into a single contig 
using SeqMan from the DNAStar© Lasergene software package, Version 8.0.2.  The 16S 
sequences were classified using the Ribosomal Database Project (RDP, Release 10, 
Update 15) Classifier and the closest cultured and un-cultured matches from GenBank 
were identified using RDP’s SeqMatch program supplemented by BLAST analysis [184-
187]. 
 
Retroviral transduction of Rag–/– thymocytes and intrathymic injection 
 Thymocytes from donor (CD45.2) Foxp3gfpRag1–/– of 5 - 8 weeks of age were 
collected and underwent “spinfection” by a MigR1-derived retrovirus which expressed 
the TCRα chain being analyzed and the TCli TCRβ chain downstream of the P2A 
sequence, as described [188]. After spinfection and a rest in culture for 1 – 2 hours, cells 
were thoroughly washed and resuspended in PBS for intrathymic injection of sublethally 
irradiated (600 rad) CD45.1 congenic 6 - 10 week old hosts. Thymocytes were then 
analyzed by flow cytometry 14 - 16 days after injection to assess for the expression of 
Foxp3gfp of CD45.2 (donor) CD4 SP cells. 
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Creation of retroviral bone marrow chimeras 
 Donor Foxp3gfpRag1-/- mice were conditioned with 5-fluorouracil before bone 
marrow was collected. After 2 d of culture in recombinant mouse IL-3 (10 ng/ml), 
recombinant human IL-6 (20 ng/ml) and recombinant mouse stem cell factor (100 ng/ml), 
bone marrow cells underwent 'spin infections' on two consecutive days with MigR1-
derived retrovirus expressing the CT2 or CT6 TCRα chain, as well as the fixed TCli 
TCRβ chain downstream of the P2A sequence [188]. On the fourth day of culture, the 
bone marrow cells were mixed with CD45.1 Foxp3gfp bone marrow harvested from 5-
fluorouracil-treated mice at varying ratios and were injected into lethally irradiated 
CD45.1 hosts (1,050 rads). In some experiments, the mice were cohoused with a mature 
female littermate of the TCliβ transgenic mice used for sequencing studies for 7-10 days, 
starting at approximately two weeks after bone marrow injection. Cells from the thymus, 
spleen, colon LP, MLN, and pooled inguinal, axillary and cervical LNs of the mice were 
analyzed by flow cytometry 8-9 weeks after bone marrow injection.
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Chapter Three: Results 
  
Colonic Treg express a unique repertoire of TCRs 
 We previously observed that the TCR repertoire of Treg show a marked skewing 
of their TCR repertoire according to location, suggesting that they home to sites 
according to their antigen specificity much as memory T cells do [150]. The intestine is a 
unique site immunologically, with its access to the commensal organisms and food 
particles of the intestinal lumen and a need to maintain tolerance to their constantly 
shifting antigens. Therefore, as an extension of our previous study we chose to sequence 
the TCR repertoire of T cells isolated from the lamina propria (LP) of the colon and 
cecum (hereafter referred to as the colon). We isolated and sorted CD4+Foxp3+ (Treg), 
CD4+Foxp3–CD44hi (memory T cells), and CD4+Foxp3–CD44lo (naïve T cells) from the 
spleen, mesenteric LNs (MLN), cervical LNs (CLN) and colon in order to compare their 
TCR repertoires. Cells were pooled from 3 or 4 mice in each of two independent 
experiments, and in a third experiment cells from the spleen, MLN and colon from five 
mice were pooled (Table 3.1). As in previous studies [33, 37, 150], these mice express 
the TCRβ chain from the TCli TCR transgenic mouse (TCliβ), the Foxp3gfp fusion 
protein reporter, and are heterozygous for TCRα locus expression, ensuring that each T 
cell expresses a fixed TCRβ chain and a single, endogenously rearranged TCRα chain. 
We sequenced the TRAV14 (Va2) chains and used the CDR3 amino acid sequence of the 
chain as a unique identifier of that TCR. 
 As we hypothesized, the Foxp3+ subset isolated from the colon showed a TCR 
repertoire that was unique, with essentially no overlap with those found in other locations  
Expt 1 Colon Spleen Mes LN Cerv LN Total
Foxp3+ 258 409 434 467 1568
CD44hi 120 451 490 398 1459
CD44lo 228 337 395 397 1357
Total 606 1197 1319 1262 4384
Expt 2 Colon Spleen Mes LN Cerv LN Total
Foxp3+ 357 283 361 284 1863
CD44hi 315 283 276 365 1927
CD44lo 281 278 306 278 1926
Total 953 844 943 927 5716
Expt 3 Colon Spleen Mes LN Total
Foxp3+ 207 142 162 511
CD44hi 197 211 193 601
CD44lo 185 148 184 517
Total 589 501 539 1629
Table 3.1 TCR sequences from experiments using
pooled animals
Number of sequences obtained from each population of cells
isolated from the indicated tissue. Each experiment consisted of
cells pooled from 3-5 mice. Cervical LN was not sequenced in
Expt 3.
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(Fig 3.1-3.2). While the repertoires of the Treg in each location did not overlap with the 
others to a large degree, the comparison with the colon was the least similar in each case, 
including, somewhat surprisingly, the MLN, with a Morisita-Horn similarity index of less 
than 0.1 in each case (Fig 3.2). As expected, the CD44lo naïve T cell repertoires were 
fairly similar across all locations, although the similarity between the colon and other 
locations was slightly lower, perhaps reflecting differences in the T cell trafficking 
patterns to the colon. The CD44hi memory T cell populations showed a somewhat skewed 
repertoire according to location, as previously reported, which held true for the colon as 
well, but there was a somewhat increased similarity seen between the colon and MLN in 
this population. In summary, our hypothesis that the colon Treg would utilize a 
particularly unique repertoire of TCRs was correct, perhaps due to the unique antigens 
available at that location. 
 Because these experiments used a pool of cells from several mice, we wished to 
compare the TCRs from individual animals in order to determine to what extent the TCR 
repertoire of the colonic Treg varied, and to identify the TCRs that are most commonly 
found on the colon Treg population. We therefore sequenced the TCRα chains from the 
colonic T cells in five individual animals (Table 3.2). This analysis revealed that the 
colonic Treg TCRs are somewhat conserved between individuals, a pattern that was also 
seen in the colon sequences from experiments using cells pooled from multiple mice (Fig 
3.3 A and not shown). In contrast, the CD44hi memory T cell repertoire showed no 
overlap between individuals; in was, in fact, difficult to find TCRs that occurred in more 
than one animal. This would suggest that the memory T cell population is directed at 
different antigens in each animal, presumably a microbial antigen from a species that is  
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Figure 3.1 Foxp3+ Treg TCRs from the colon are unequally distributed. 
 The anatomical distribution of the most abundant TCR sequences within each phenotype 
are shown. Using the average frequencies from the pooled TCR datasets from all three 
experiments, the top 50 TCR sequences within a given phenotype were selected. For each 
TCR, the relative frequency with which it is found at each anatomical location was 
calculated by dividing its frequency at each location by the sum of the frequencies at all 
locations. The frequency is represented on the heat map by decile, with the scale 
indicating the colors at 100 (red), 66, 33, and 0% (yellow) for a TCR at a given location. 
The data are clustered such that those TCRs predominantly found in one location are 
shown together. 
Figure 3.1 Foxp3+ Treg TCRs from the colon are unequally distributed.
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Figure 3.2 Statistical analysis of similarity between populations from different 
anatomical locations. The Morisita-Horn similarity index is shown for the comparison 
between the colon and the mesenteric LNs (MLN), spleen (SPL) and cervical LNs (CLN) 
in the first set of each panel, then between the spleen and the MLN and CLN, then 
between the MLN and CLN. Values are for the comparison between datasets combined 
from all three experiments. 
Figure 3.2 Statistical analysis of similarity between populations from
different anatomical locations
COLON
M
LN
C
LN
SP
L
Vs. SPL
C
LN
M
LN
MLN
C
LN
Foxp3+ CD44lo CD44hi
COLON
M
LN
C
LN
SP
L
SPL
C
LN
M
LN
MLN
C
LN
COLON
M
LN
C
LN
SP
L
SPL
C
LN
M
LN
MLN
C
LN
1.0
0.8
0.6
0.4
0.2
0
M
or
is
ita
-H
or
n 
S
im
ila
rit
y 
In
de
x
-112-
Colon mouse 1 mouse 2 mouse 3 mouse 4 mouse 5 Total
Foxp3+ 200 175 224 214 138 951
CD44lo 209 189 201 190 176 965
CD44hi 179 187 174 242 194 976
Total 588 551 599 646 508 2892
Table 3.2 TCR sequencing of colon T cell from individual animals
Number of sequences obtained from each population of colon/cecum
lamina propria T cells from each of 5 individual mice.
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Figure 3.3 Comparison of the colonic TCR repertoires of five individual mice. (A) 
The mean (±SEM) of the Morisita-Horn similarity indices of each pairwise comparison 
between the TCR repertoires of the Foxp3+ (green), naïve CD44lo (blue), or memory 
CD44hi (gold) populations of five individual mice (Table 3.2). (B) Comparisons between 
the TCR repertoires of the Foxp3+, CD44hi, and CD44lo population within each of the five 
individual mice. The mean (±SEM) of the Morisita-Horn indices of these comparisons is 
shown. 
Figure 3.3 Comparison of the colonic TCR repertoires
of five individual mice.
Comparisons of populations from
different individual mice.
Comparisons of different phenotypes
found within the same mouse.
A
B
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rare or transient, or a potentially pathogenic bacterium that was eliminated by the 
immune response. In contrast, it appears that the Treg population recognizes fairly 
conserved antigens; either true self antigens which are unique to the colon, and/or broadly 
represented bacterial antigens that are either conserved between multiple bacterial species 
or derive from very abundant and widespread species.  
 In agreement with our previous study [150], there was very little overlap in the 
TCR repertoires of the Foxp3+ Treg, CD44lo naïve, and CD44hi memory T cell 
populations. We had hypothesized there may be an increased similarity between the 
CD44hi memory and Treg populations if indeed a sizeable number of colonic Treg arise 
via peripheral conversion, as this might occur alongside effector cell development to the 
same antigens. To the contrary there was almost no shared TCRs between these two 
subsets, with an average M-H value well below 0.1 (Fig 3.3 B), further supporting a 
model where T cell differentiation occurs in response to different stimuli in these two 
populations. In addition, there was no significant similarity between the Treg and naïve T 
cells in the colon (Fig 3.3 B). 
 
Some common colonic Treg TCRs recognize bacterial antigens 
 In an attempt to determine if we could identify the antigens being recognized by 
colonic Treg TCRs we selected several prominent TCRs that were found at relatively 
high frequency within multiple mice and/or experiments, and were not found within the 
CD44lo or CD44hi datasets. This criteria ensures that we are only considering the most 
conserved Treg TCRs, which we believe should encompass a representative sampling of 
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typical Treg TCR specificities. These TCRs, and their prevalence in each dataset, are 
listed in Table 3.3.  
 We transduced a T cell hybridoma line expressing an NFAT-driven GFP reporter 
(as a way to assess TCR engagement) and the TCli TCRβ chain with these TCRα chains 
to create reporter hybridomas with the specificities of the most common colonic Treg. 
These were sorted by flow cytometry to obtain a population with consistent TCR 
expression and minimal background GFP expression. These hybridomas were then 
cultured with a variety of antigens and Flt3L-induced splenic DC, and assayed for NFAT-
GFP expression by flow cytometry as indication of antigen recognition by the TCR. 
 We sought to test these hybridomas for reactivity against common commensal 
bacteria. In order to obtain as wide a variety as possible of the species typically found in 
the colon of these mice we harvested the colon and cecum contents from wild-type 
littermates of the TCliβ transgenic TCRα heterozygous mice being used for TCR 
sequencing. The commensal microbiota can vary widely between animals according to 
their genetics and housing conditions . Therefore, we believe the use of these littermate 
mice is the best approach to obtain bacterial isolates that will be relevant to the particular 
Treg population we have been studying.  
 Aerobes and anaerobes were isolated from the colon contents by growth on 
various nutrient agars in various conditions (see Materials and methods). Individual 
colonies appearing to be different species by colony morphology were subcloned and 
either grown in liquid media culture, or, for species that wouldn’t grow to sufficient 
density in liquid medium, replated again at higher density and the resulting colonies 
scraped from the plate. These bacteria were heat-killed and then frozen for later use. In  
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total, 77 isolates were obtained for screening; as the media and growth conditions used 
were fairly non-specific it is likely that several of these preps may consist of the same 
bacteria grown in more than one condition. Each of these isolates was given a name 
related to the type of agar on which it was grown and a randomly assigned number, and 
pools of 2 to 3 isolates each were created to facilitate screening. In addition, the colon 
and cecum contents were prepared from another TCliβ TCRα+/– littermate control mouse, 
as well as a C57BL/6 germ-free mouse (see Materials and methods). These likely will 
contain bacteria that were not culturable with our current techniques, but that may still be 
recognized by our TCRs.  
 T cell hybridomas expressing colonic Treg TCRs were cultured with Flt3L-
elicited splenic DC and pools of bacterial preps or autoclaved colonic/cecal content preps 
(ACP). Flow cytometry to detect NFAT-GFP showed that several of the TCRs appear to 
recognize antigens present in the ACP from the TCliβ littermate mouse (Fig 3.4 and 3.5), 
but did not show reactivity to the C57BL/6 germ-free ACP. In addition, three TCRs 
showed reactivity to one or more of the pools of bacterial preps (Fig 3.5). Upon screening 
the individual components of these pools, it was found that each of these TCRs reacted 
specifically to one or more individual bacterial isolates present in the pools (Fig 3.6 and 
Table 3.4) This reactivity was dependent upon the presence of the DCs in the culture and 
was abrogated by the addition of a blocking antibody to MHC class II (Fig 3.7). 
Therefore, 7 of the 12 prevalent colonic Treg TCRs tested showed some reactivity to 
bacterial-derived antigens. 
 The identity of several isolates from the pools to which a hybridoma was reactive 
was determined by 16S rRNA sequencing of the isolates, and the results are shown in  
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Figure 3.4 Examples of screening results of CT7- and G57-expressing hybridoma 
cells. Shown are representative plots demonstrating the flow cytometry assessment of 
hybridoma reactivity by the percentage of Vb6+Va2+ cells that express the NFAT-GFP 
reporter following culture with APC + the indicated antigen or no antigen control (far 
right) used to assess background fluorescence. ACP, autoclaved cecum/colon prep. 
αMHC cII, blocking antibody to MHC class II was added. 
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Figure 3.5 Screening of hybridomas expressing prevalent colon TCRs against a 
panel of bacterial antigen pools and cecal/colonic content preparations. Hybridomas 
expressing the TCRs indicated and an NFAT-driven GFP reporter were screened by 
culture with Flt3L-elicited DC and the indicated antigen. After 40-44 hours hybridoma 
cells were stained for TCR expression and the percentage of cells that expressed GFP was 
measured by flow cytometery, as shown in Fig 3.4. The fold-increase over the percentage 
of cells expressing GFP in the no antigen added control culture was calculated for each 
sample and is shown on the bar graph. Screens of those hybridomas listed in Table 3.3 
that did not show any reactivity are not depicted. ACP, autoclaved cecum/colon prep. G-
F ACP, ACP from a germ-free mouse.  
Figure 3.5 Screening of hybridomas expressing prevalent colon TCRs against a
panel of bacterial antigen pools and cecal/colonic content preparations.
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Figure 3.6 Reactivity to individual bacterial isolates by hybridomas expressing the 
CT2, CT6 or CT7 T cell receptors. The three hybridomas that showed reactivity to a 
pool of bacterial isolates in the assays depicted in Fig 3.5 were then screened against the 
individual components of that pool to determine which isolates they respond to. The fold-
increase over the percentage of cells expressing GFP in the no antigen added control 
(shown on the right) is shown on the bar graph. Green bars show the reactivity to the 
pools (or no antigen control) and orange bars show the reactivity to the individual isolates 
which make up the pool shown on their left.  
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Figure 3.7 Hybridoma reactivity to bacterial antigens is dependent upon 
presentation of antigen on MHC class II by APC. Shown are screens of the 
hybridomas indicated against the specific bacterial isolates with (green) or without 
(orange) addition of blocking antibody to MHC class II.  Shown in blue are cultures in 
which no APC were added (No APC). acII, blocking antibody to MHC class II. 
Figure 3.7 Hybridoma reactivity to bacterial antigens is
dependent upon presentation of antigen on MHC class II
by APC
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Table 3.4 Summary of reactivity observed for each
colon Treg TCR hybridoma tested.
Reactivity
CT1 AASWASGYNKLT ACP
CT2 AASAIWNTGYQNFY ANB 8.1 & 8.2, ACP
CT7 AASATGDNRIF ANB 10, LKV 7, LKV 8
G57 AASELYQGGRALI ACP
CT4 AASEYSALGRLH none
CT6 AASGYSALGRLH ACNA 18.1 & 23, ACP
CT8 AASLTGGYKVV none
CT9 AASADNRAGNKLT ACP
CT11 AASAPWNSNNRLT ACP
CT12 AASAVWANTGKLT none
CT10 AAQRRGNYKYV none
CT13 AASRERYANKMI none
Colon Treg TCR
ACP = Autoclaved colonic/cecal content prepResults of screening hybridoma expressing the indicated TCR
against bacterial preps and ACP. Green=reactive to a specific
bacterial prep. Gold=reactive to ACP but no specific bacteria
identified. ACP=Autoclaved colonic/cecal content prep
-128-
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Table 3.5. In each instance in which a hybridoma was reactive to more than one isolate, 
sequencing revealed that these isolates appeared to be identical, and the bacteria had 
likely been isolated more than once. Those isolates in the pools which did not cause 
hybridoma reactivity were found to be completely unrelated to the isolates that did, 
further confirming that each of these TCRs recognizes an antigen found only a specific 
species or in closely related species. In addition, the three bacteria that caused reactivity 
are from different phyla or orders, and are therefore not at all closely related to each 
other. Therefore, it seems that a diverse selection of bacteria may be recognized by 
colonic Treg. 
 
T cells expressing colonic Treg TCRs do not become Foxp3+ in the thymus. 
 Most Treg are selected to become Foxp3+ regulatory cells during thymic 
development, presumably due to recognition of a thymically-presented self antigen. 
Therefore, the realization that many colonic Treg TCR recognize bacterial antigens, 
which presumably would not be available in the thymus, led us to wonder whether these 
Treg arose via peripheral conversion from mature non-regulatory cells, or if they are 
thymically-selected Treg which happen to cross-react with bacterial antigens. We chose 
several of the top colon Treg TCR to test, as well as a three Treg TCR normally found in 
other sites in the body, two of which we have previously shown undergo thymic Treg 
development (G25 and R19) [189], and as a negative control, a TCR only found on naïve 
T cells (B8) (Table 3.6). To test the induction of Foxp3 expression in the thymus by cells 
expressing these colonic Treg TCR we retrovirally introduced the TCli TCRβ chain and 
TCRα chain in question into thymocytes from Foxp3gfp Rag1–/– mice. As these mice  
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cannot rearrange their endogenous TCRβ chain there is an accumulation of cells in the 
CD4–CD8– (DN) stage; only those cells which are successfully transduced will be able to 
progress through positive and negative selection. The thymocytes were then injected into 
the thymus of a CD45.1 congenic host in order to allow development to take place, and 
after 14-16 days the thymocytes from these host animals were analyzed by flow 
cytometry. The donor thymocytes expressing the TCR of interest were identified by 
CD45.2 expression, as well as Vβ6 and Vα2, and analyzed for the expression of Foxp3gfp 
(Fig 3.8 A). 
 We found, as expected, that the three Treg TCR normally found in non-colonic 
sites in the mice, R19, R111 and G25, showed induction of Foxp3gfp in this assay (Fig 3.8 
B, red dots). In agreement with previous results, we saw that a higher percentage of G25-
expressing CD4 SP thymocytes expressed Foxp3 compared to R19-expressing cells 
[189]. The R111 TCR showed a similar efficiency of Foxp3 induction as R19. The naïve 
TCR, B8, did not show any Foxp3 expression, as would be expected. These results verify 
this assay as capable of identifying TCRs that are normally mediate selection into the 
Foxp3+ regulatory cell lineage within the thymus. 
 In stark contrast, all 8 colonic Treg TCRs tested in this assay showed no Foxp3 
expression in the thymus (Fig 3.8 B, green dots). This included a TCR that did not show 
any detectable bacterial reactivity with the hybridoma screening, CT4. These results 
suggest that these colon Treg TCR do not encounter antigen in the thymus, but leave the 
thymus as naïve T cells which upregulate Foxp3 upon antigen recognition in the colon. 
This may be a result of interaction with a CD103+ DC presenting antigens derived from 
commensal bacteria, as this subset of gut DC has been shown to efficiently mediate  
-133- 
 
 
 
 
Figure 3.8 Foxp3 expression by thymocytes expressing selected Treg TCRs or a 
naïve control TCR.  Thymocytes from Foxp3gfpRag1–/– CD45.2+ donor mice were 
transduced with the indicated TCR and injected into the thymus of a sublethally 
irradiated CD45.1 recipient mouse. (A) (top) Gating strategy used to identify donor CD4 
SP thymocytes expressing the transduced TCR 14-16 days after transfer. (bottom) 
Representative plots showing the level of Foxp3gfp expression by recovered thymocytes 
expressing the R19, CT7, or B8 TCRs, as indicated. (B) Graph plotting the percentage of 
recovered donor CD4 SP thymocytes expressing Foxp3gfp for each tested TCR. Each dot 
represents one animal; data from each TCR is from at least two individual experiments. 
Red TCRs are those normally found in non-colon Treg populations (shown in pink in 
Table 3.6), while those in green are colon Treg TCRs (green in Table 3.6). In blue is the 
control naïve T cell TCR, B8. 
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Figure 3.8  Foxp3 expression by thymocytes expressing selected Treg TCRs or naïve
control TCR.
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peripheral conversion, as well as upregulate gut-homing receptors on T cells [44, 124, 
129]. As these TCR were all found to be quite abundant in the colon Treg TCR 
repertoire, it is likely that peripheral conversion plays a larger role in the generation of 
this population than previously suspected. 
 
T cells expressing colonic Treg TCRs in vivo do not express Foxp3 in the thymus, but 
upregulate Foxp3 upon encountering bacterial antigen in the periphery. 
 To further investigate the possibility that these colon Treg are a product of 
peripheral conversion rather than thymic Treg selection we chose to create retroviral 
mixed bone marrow chimeras expressing the CT2 and CT6 TCRs.  These TCRs were 
shown to recognize specific bacterial antigens (Fig 3.5 and Table 3.4), and did not appear 
to undergo thymic selection into the Treg pool (Fig 3.8 B). Retroviral bone marrow 
chimeras were created by mixing Foxp3gfpCD45.1+ congenic bone marrow with (CD45.2) 
Foxp3gfpRag1–/– bone marrow transduced with a retrovirus encoding the TCli TCRβ 
chain and either the CT2 or CT6 TCRα chain (see Materials and methods). These mice 
were allowed to reconstitute their T cell populations for 8 – 9 weeks, and then cells from 
the thymus, spleen, MLN, pooled axillary, inguinal and cervical LN (referred to as 
“peripheral”LN or PLN) and the colon/cecum LP were isolated and analyzed by flow 
cytometery.   
 Initial experiments confirmed that there was no detectable expression of Foxp3 in 
the CT2- or CT6–expressing thymocytes (orange symbols, Fig 3.9 A and 3.10). However, 
these initial experiments also did not show any Foxp3 expression by the CT2- or CT6-
expressing cells recovered from the periphery, including the colon LP. We suspected that  
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Figure 3.9 Foxp3 expression by T cells expressing the CT2 TCR in mixed retroviral 
bone marrow chimeras. Bone marrow chimeras were made with a mixture of wild-type 
CD45.1+ bone marrow and CT2-transduced CD45.2+ bone marrow from Foxp3gfpRag1–/– 
donors, and injected into CD45.1+ lethally irradiated recipients. At 8-9 weeks of post-
injection the CD45.2+ T cells were recovered from the thymus, spleen, mesenteric LN, 
the axillary, inguinal and cervical LNs (pooled) and the colon lamina propria. The 
percentage of CT2-expressing CD4 SP (thymocytes) or CD4+ T cells expressing Foxp3gfp 
was assessed. (A) Results of experiments in which the chimeras were allowed to develop 
undisturbed (orange) or cohoused approximately two weeks after injection with a 
littermate mouse of the TCli TCRβ transgenic mice used for sequencing studies (Fig 3.1-
3.3, Tables 3.1 and 3.2) (green). Each symbol is represents an individual animal, and data 
is from 3 individual experiments. (B) Additional experiment as described in A, in which 
the chimeras were cohoused as described. The data from this experiment is shown on a 
separate graph for clarity due to the development of a higher percentage of Foxp3+ cells. 
Figure 3.9 Foxp3 expression by T cells expressing the CT2 TCR in mixed retroviral
bone marrow chimeras.
A
B
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Figure 3.10 Foxp3 expression by T cells expressing the CT6 TCR in mixed retroviral 
bone marrow chimeras. Bone marrow chimeras were created with CT2-transduced 
CD45.2+ bone marrow from Foxp3gfpRag1–/– donors as described in Fig. 3.9. As before, 
the percentage of recovered CT2-expressing cells that are Foxp3+ is shown, and orange 
symbols represent mice that were not cohoused, while green symbols represent those that 
were. Data is from four individual experiments. 
Figure 3.10 Foxp3 expression by T cells expressing the CT6 TCR in mixed
retroviral bone marrow chimeras.
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this might be due to a lack of the appropriate bacteria in the gut. The recipient mice in 
these experiments were obtained from the National Cancer Institute (NCI), and since they 
were not bred in our colony their colonic microbiota might have a different composition, 
and therefore be missing the bacteria recognized by CT2 and CT6. 
 Therefore, in repeat experiments we cohoused the chimeras for 7-10 days with a 
female TCli TCRβ chain littermate mouse, starting at approximately two weeks after 
bone marrow injection, to see if the bacteria could be transferred between the animals. 
Indeed, in the mice which had been cohoused, analysis of the peripheral T cells, 
particularly the colon LP T cells, showed Foxp3gfp expression in the CT2- or CT6- 
expressing cells (Fig 3.9 A and B, 3.10, green symbols). Non-cohoused animals 
continued to show no sign of Foxp3 expression (orange symbols). Therefore, it seems 
that colon Treg expressing the CT2 or CT6 TCR are a product of peripheral conversion, 
which occurs as a result of bacterial-derived antigen recognition in the colon. 
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Chapter Three: Discussion 
 With these experiments we have demonstrated that the colon Treg population 
expresses a unique repertoire of TCRs, which does not overlap with those used by Treg in 
the other locations in the body that we have sequenced, nor with the CD44hi memory T 
cell population. The very distinct set of antigens recognized by these T cells may in large 
part be derived from the abundant commensal microbiota, as we have gone on to show 
that the most prominent colon Treg TCR recognize bacterial antigens. Furthermore, T 
cells expressing these TCRs do not show signs of expressing Foxp3 during selection in 
the thymus, suggesting that Foxp3 expression is a result of peripheral conversion. Indeed, 
for T cells expressing two of these bacterial reactive TCRs, CT2 and CT6, we have 
confirmed that no Foxp3 expression is seen during thymic development in a retroviral 
bone marrow chimera. In these mice, Foxp3 expression occurs only in the periphery, and 
is dependent upon commensal bacteria found in the TCli TCRβ transgenic mice used in 
our TCR sequencing studies. In summary, we have directly shown for the first time that 
some colonic Treg cells develop in response to peripheral conversion due to recognition 
of antigens derived from the commensal microbiota. 
 That peripheral conversion would be a source of colonic Treg is not particularly 
surprising in light of data showing abundant conversion in the small intestine and MLN 
in models of oral tolerance [44, 124]. Conversion in the small intestine is mediated by 
lamina propria CD103+ DC which can transport antigen to the MLN to present antigen to 
naïve T cells . Here we show evidence that peripheral conversion also plays a role in the 
shaping of the Treg repertoire in the colon, as well, presumably through the same 
mechanism. 
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 The lack of similarity between the colonic and MLN Treg repertoires is somewhat 
surprising, particularly in light of these results. One study has shown that for peripheral 
conversion to occur in a model of alloantigen tolerance the T cells must be able to occupy 
the lymph nodes; T cells from mice that did not express CD62L were not converted, 
presumably due to an inability to access the LN and interact with the APC mediating 
conversion [190]. It has also been shown that antigen presentatio in the MLN is required 
for oral tolerance induction [191]. It is unknown if this also holds true for T cells in the 
colon, as the lymphoid architecture in this region is unique. The majority of the MLN 
drain the small intestine rather than the colon, so while this may be a site of peripheral 
conversion against small intestine antigens, it may not hold true for colonic antigens. The 
colon lamina propria contains isolated lymphoid follicles (ILF) that might act as an 
additional site of conversion. Studies of germ-free mice have shown that the development 
of the ILFs is dependent upon the presence of the commensal microbiota, and that the 
bacterial load and composition affect the size and number of ILFs [192]. It is possible 
that the ILFs, with their proximity and responsiveness to the commensal microbiota, are 
actually the major site of T cell/DC interaction in the colon. 
 We were surprised at the number of prominent colon TCRs which showed 
bacterial reactivity. It would be expected that many bacterial-responsive TCRs did not 
show reactivity in our screen because they recognize a bacterium which was not present 
at a sufficient concentration in the ACP, and therefore the number of TCRs which were 
positive in our assay probably underestimates the true number.  While several of the 
TCRs recognized ACP, we were able to pinpoint the reactivity to specific bacteria 
cultured out of mice in our colony for only three TCRs (one of which, CT7, did not show 
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reactivity to ACP). It is estimated that less than half of the bacterial species in the 
microbiota are uncultureable by currently developed methods . Therefore, the four ACP-
reactive TCRs which did not react to any of our bacterial isolates likely recognize 
antigens from organisms we were unable to culture.  
 The high number of TCRs reactive to ACP (6 of the 12 tested) may reflect the 
ability of more abundant commensal organisms to induce Treg directed against them. 
This may be a bacterial-driven process, such as the production of a molecule that assists 
in tolerance induction, or properties that maintain a tolerogenic state in APCs upon their 
phagocytosis. Tolerance may also just be a passive result of the lifestyle of these bacteria. 
For instance, they may favor a location which facilitates their uptake in a way that 
promotes tolerance. In effect, the ability to induce Treg tolerance may be a hallmark of a 
successful commensal organism, and may help explain the fairly conserved colon Treg 
TCR repertoire across multiple mice and experiments.  
 Our selection criteria of choosing colon Treg TCRs which are found almost 
exclusively in the colon, and were detected in multiple experiments (see Table 3.3), may 
have selected for bacterial-reactive TCRs. While it would be expected that some colon 
Treg recognize conserved self antigens, these TCRs may be found in other locations as 
well, and therefore not chosen by us for further study.  However, the low similarity 
between colon and other organs studied suggest that these Treg are in the minority (Fig. 
3.2) It may be that these Treg are outcompeted by the bacterial-reactive Treg in the colon, 
which probably receive frequent restimulation by APCs that continue to encounter these 
abundant bacterial antigens. DC are not the only cell type in the intestine which can 
present bacterial antigens, and therefore the Treg may also encounter their cognate 
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antigens on macrophages and on the intestinal epithelial cells (IEC), which also express 
MHC class II.  It is possible that in the absence of bacterial-reactive Treg, more Treg 
recognizing conserved self antigens would inhabit the intestines and be capable of 
maintaining homeostasis to some degree. For example, in mice lacking a conserved 
noncoding sequence in the Foxp3 gene required for peripheral conversion, there is a 
reduction in the size of the Treg population of the GALT, but these mice do not 
spontaneously develop inflammation [149]. It would be interesting to see whether these 
mice are at increased risk for IBD development if crossed to models of spontaneous 
colitis development, or if the existing colon Treg repertoire that develops in these mice 
would be as efficient as wild type Treg in preventing disease in the classic model of 
transfer colitis. 
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Chapter Four: Discussion 
Is antigen specificity necessary for regulatory T cell suppression? 
 The research detailed in this thesis centers around the part that antigen specificity 
plays in Treg function. It can be inferred from our results that, in vivo, Treg often do have 
antigen specificity. This is the simplest explanation for the segregation of TCR usage 
seen in the Treg populations of the spleen, lymph nodes, and even the colon. However, 
that does not mean that Treg must have this antigen specificity to perform their function, 
although most people agree that Treg need to receive TCR stimulation to mediate their 
suppressive functions [51, 76]. 
 There are studies suggesting that Treg can act to suppress T cell effector function 
against antigens which they do not themselves recognize. For example, in a model of 
autoimmune gastritis, in which polyclonal T cells were able to prevent disease through 
“bystander suppression” [72, 73]. A follow-up paper by this group, however, reported 
that antigen-specific Treg were better suppressors in this system. In a model of Friend 
virus infection of the hematopoietic system in which a lack of regulatory activity will 
result in anemia, it was found that the Treg capable of preventing the anemia were not 
specific for Friend virus [193]. Additionally, a common model of colitis relies on the 
transfer of non-regulatory T cells into a lymphopenic host, and disease is prevented by 
the co-transfer of a population of Treg. However, it seems unlikely in this system that 
most of the Treg transferred are specific for gut antigens, as they generally not isolated 
from the GALT. Treg isolated from germ–free mice were reported to be fully capable of 
preventing disease in this same transfer model, although they were not as efficient as 
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those from conventional mice [148]. However, there is also a report that Treg from germ-
free mice are unable to prevent disease in this model [147].  
 These studies appear to conflict with others that demonstrate antigen specificity of 
Treg. In one paper it was shown that in vitro Treg with a known antigen specificity 
capable of suppressing effector cells with the same specificity, but not those with a 
different defined specificity [75]. Additionally, studies showing that protection from 
organ autoimmunity relies on Treg cells that arose in an animal containing the organ in 
question suggest that only Treg specific for that organ can prevent disease [78, 80, 155].  
 These data are most easily reconciled by the theory that Treg are most effective at 
suppression of T cells when the antigens recognized by each are presented on the same 
APC (which would most commonly occur when these antigens arise from the same tissue 
or organism), but they can also mediate non-specific suppression less efficiently. 
Improved efficiency of suppression is likely to be a result of mechanisms that rely on 
direct interactions between the Treg and the effector cell, and/or tolerogenic effects the 
Treg may have on the APC. Therefore, this allows for very efficient protection of those 
potential targets for which Treg are specific, and explains how they are able to maintain 
homeostasis even while they are outnumbered in vivo. However, if a Treg in the vicinity 
of an effector cell is receiving TCR stimulation it might have a non-specific tolerogenic 
effect on its surrounding through the release of cytokines. The ability of Treg to control T 
cells with a different antigen specificity may therefore be a numbers game – if you have 
enough of these cells, they will abrogate the immune response through passive 
suppression, possibly combined with the effect of some Treg recognizing its antigen on 
an APC that happens, by chance, to also present antigen to the effector cell. The 
-147- 
combination of these will then, somewhat less efficiently, be capable of controlling 
responses in a “non-specific” way. 
 The pattern of localization seen by regulatory T cells is similar to the localization 
of antigen-experienced memory T cells. T cells are conditioned to stay in the area in 
which they recognize antigen and become activated, and regulatory T cells, as antigen-
experienced cells, are no exception. Since Treg do require stimulation through their 
antigen receptor to suppress, whether or not their target is also recognizing the same 
antigen, it makes sense to keep them in the area in which they will find that stimulation. 
Therefore, as with memory T cells which are most effective at maintaining immunity it 
kept at the ready in the site where the antigen previously turned up, this pattern of 
localization improves the likelihood that a Treg will receive the stimulation it requires to 
do its job efficiently. 
 
Does peripheral conversion play a role in the non-mucosal immune system? 
 Many studies in which antigen was supplied in vivo under non-inflammatory 
conditions have shown that peripheral conversion of mature T cells into Foxp3+ 
regulatory T cells CAN occur [38, 39, 41, 162, 194, 195]. There doesn’t seem to be any 
special characteristic of the T cells able to undergo conversion; it seems that if you 
present a T cell with its cognate antigen under the right conditions it may become a Treg. 
Our data suggests that only T cells expressing a certain subset of TCR can be converted 
(Fig 2.15). However, in vivo, this restriction likely has more to do with the antigens than 
the TCR or T cell properties. Only certain antigens will be presented under the proper 
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conditions for Treg to develop, therefore limiting the T cells capable of converting to 
those able to recognize this subset of antigens.  
 This ability of T cells to become regulatory serves as an excellent way to enforce 
tolerance to certain antigens, whether or not they were presented in the thymus. The body 
needs a system by which tolerance can be maintained to newly acquired or manufactured 
antigens, or even typical self antigens which may not be thymically presented. Further, 
even antigens which are expressed in the thymus are often expressed at low amounts, and 
it would be impossible for all T cells to encounter all possible antigens. This results in 
some T cells which strongly recognize self antigens escaping negative selection, and it 
has been clearly shown that there are self-reactive T cells normally in the body; in the 
absence of proper regulation these cells can cause autoimmunity. The flip side of this 
antigen limitation is that some potential Treg will also escape their induction into the 
Treg lineage, and enter the periphery as a typical naïve T cell. 
 This limited niche for Treg development was demonstrated by the recent paper 
from our lab showing that, for any one particular TCR specificity, there are a limited 
number of Treg that can be induced [189]. This number varies, most likely depending 
upon the availability of the particular antigen recognized. If you have a large number of T 
cells with a particular specificity, they cannot all receive sufficient signal to become 
Treg, and a lower percentage of these cells will upregulate Foxp3 in the thymus. In the 
TCR transgenic mouse expressing a Treg TCR, G113, there was no Foxp3 induction in 
the thymus. However, if the prevalence of these cells in the thymus was reduced by 
mixing with polyclonal T cells in a mixed bone marrow chimera, suddenly the G113 cells 
no longer overwhelmed the supply of their (unknown) cognate antigen, and some were 
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able to receive the signal to become a Treg. The TCR transgenic mouse did, however, 
show some Foxp3+ cells in the periphery even when there was no visible thymic 
development. These cells may be a result of a “second chance” at Foxp3 induction for 
cells that missed out on the opportunity in the thymus by peripheral conversion.   
 Our studies and others estimate that peripheral conversion does not contribute a 
large amount to the normal Treg repertoire. This is probably because only a few cells will 
require this “second chance” mechanism, which may account for the small number of 
Treg (4-7%) estimated to arise from conversion in the secondary lymphoid organs. 
However, during ontogeny the contribution may be greater, as the emerging T cells enter 
the somewhat lymphopenic periphery. Homeostatic expansion facilitates conversion [42, 
43].  As we showed in Fig. 2.15, however, even conversion in a lymphopenic 
environment depends upon the TCR specificity; only those T cells receiving antigenic 
stimulation in the correct environment will become Treg, and therefore only the T cells 
recognizing self antigen will become regulatory. 
 It does seem, however, that peripheral conversion is not absolutely required to 
maintain homeostasis. A recent study identified a conserved, non-coding sequence in the 
Foxp3 gene which appears to be involved in peripheral conversion [149]. In spite of this 
defect, mice that are deficient in this region showed no spontaneous development of 
autoimmunity. There is likely to be a proportionally small number of cells in the 
periphery which have “missed” becoming Foxp3 in the thymus in a fully polyclonal 
animal, and therefore the thymically-derived Treg population is sufficient to maintain 
tolerance. Additionally, while conversion was reduced, it was not absent in these mice. 
However, it may be interesting to push this system and see if this lack of conversion does 
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affect the health of the mice under various conditions.  For example, it has been reported 
that during infection with a pathogen, Treg can arise alongside Teff cells, and are thought 
to help restrain and shut down the immune response. Infection of these mice might show 
increased tissue damage, possibly increasing their mortality in response to certain 
pathogens. However, some pathogens that rely on induction of Foxp3+ Treg in order to 
establish chronic infections (such as Leishmania major) might be cleared by these 
animals [47].  
 
Peripheral conversion and tolerance in the gut. 
 While it makes sense that peripheral conversion is not required on a large scale in 
much of the body, the mucosal immune system is in contact with an ever changing array 
of non-self antigens, and therefore it seems reasonable that Treg specific for harmless 
commensal organisms would be advantageous. As antigens derived from these organisms 
are unlikely to be transported to the thymus, at least in any useful amount, most Treg 
specific for commensal bacteria are likely to arise via conversion. Our data shows that 
many commonly found Treg in the colon do not arise from thymic Treg selection, and 
instead appear to develop in the periphery in response to exposure to bacterial antigens. 
While this may have been suspected, it is the first time that it has been shown that Treg 
recognize antigens derived from specific bacteria, and it seems that, at least in our 
experimental system, a large portion of the most prevalent Treg in the colon are actually 
bacterially-reactive. As an extension of these studies, it would be excellent to see if the 
Treg segregate even further within the various sections of the colon and cecum. The 
cecum could be processed on its own, and the colon separated into the ascending colon, 
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transverse colon, and rectum/anal-rectal junction. If the Treg in these portions do show 
differences in their TCR usage, it would be very useful to correlate the natural habitat of 
the bacteria to which these Treg are specific to the Treg localization, if possible. 
 In the previously-mentioned study of the Foxp3 CNS1-deficient mice [149], T 
cells show a defect in peripheral conversion, and have a lower number of Foxp3+ cells in 
the gut-associated immune system. In spite of this, they report no development of 
spontaneous gut inflammation in these animals. This may seem surprising considering the 
evidence that conversion plays a large role in the formation of the Treg repertoire at this 
location. However, in these mice conversion is not completely absent, just reduced.  
Therefore, enough cells may created to keep homeostasis intact, at least in an unperturbed 
system. They also have not specifically shown that the reduction is due to a lack of 
conversion rather than a shorter lifespan of these converted Treg; they may, by their 
nature, be less stable. Therefore, at any one time the gut immune system may contain a 
reasonable array of bacterial-specific Treg capable of preventing disease, even if they 
may not survive as long. It would be very interesting to compare the repertoire of TCRs 
of the Treg populations in the CNS1-deficient and wild-type mice; this should allow for 
the determination of whether the cells expressing typical Treg TCRs do not become 
Foxp3+, or are simply reduced in frequency. The authors also speculate that some T cells 
which would normally become Treg may instead become IL-10 producing Tr1 cells; this 
theory could also be tested by the sequencing of these mice crossed to an IL-10 reporter 
mouse [25]. 
 The real challenge of maintaining a healthy intestine becomes evident during 
infection with a pathogen. During such an event, there is often a breakdown in the mucus 
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layer and epithelial barrier, with a resulting high level of interaction between effector T 
cells and both the pathogenic and non-pathogenic commensal organisms. To restore 
homeostasis after such a pathogen is cleared and curb inflammation to allow repair of the 
mucosal barrier is likely a challenge requiring the highest level of suppressive activity 
available. In the absence of the normal number of the bacterially-responsive Treg capable 
of efficiently suppressing reactivity to the commensal organisms, a chronic inflammatory 
response may develop in the aftermath of such an event. Therefore, it would be 
interesting to see whether these mice develop intestinal inflammation after infection with 
an intestinal pathogen. Although the authors saw no difference between the CNS1 KO 
mice and wild-type mice in resolution of DSS-mediated colitis, it has been shown 
inflammation in this model is not T cell dependent [196], and therefore resolution may 
not require a full Treg repertoire, and the increased number of IL-10-producing Tr1 cells 
seen in these mice may instead compensate.  
  
Therapeutic considerations of regulatory T cells in disease 
 The fact that Treg play an important role in maintaining immune homeostasis and 
the observations that these cells are often lacking in either numbers or suppressive 
capability in autoimmune diseases has led to the attempt to use these cells therapeutically 
[197]. Strategies are two-fold; induce and expand Treg in vivo, or collect cells and 
convert/expand them in vitro, for reintroduction into the patient. Many current IBD 
therapies such as steroid regimens, neutralization of TNFα, and blockade of IL-12p40 (as 
a component of both IL-12 and IL-23) may reduce innate immune activation but may also 
have the ability to enhance Treg function or induce Treg, possibly through the restoration 
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of a permissive cytokine environment [177, 198, 199]. However, these broad-based 
treatments can lead to unwanted side effects and susceptibility to infectious disease, so 
more specific ways to target Treg are being developed [197].  
 Efforts to collect T cells from patients and then expand or induce Treg in vitro 
have not so far been very successful [200]. There is not yet a reliable way to convert 
human conventional T cells into stable, functional Treg in vitro on any large scale. 
Expansion of Treg is hindered by the relatively low proportion of Treg in the blood, a 
lack of a good technique to efficiently purify them away from the conventional T cells, 
and the very large number of cells required to make a therapeutic difference. Most likely 
the large number required is due to the lack of Treg specificity in this approach. In mouse 
models of diabetes and IBD, the successful cure of ongoing inflammation by 
administration of Treg required the Treg to be antigen-specific [201]. Of course, in most 
cases it is not practical to obtain antigen-specific Treg from humans, and this is where the 
potential therapy has reached its largest stumbling block. It has been proposed that 
perhaps a vaccination of antigenic peptide may expand specific Treg in vivo, as a way to 
get around this limitation [201] 
 It has been discovered that certain species of commensal bacteria can help to curb 
inflammation in the gut; these bacteria have been termed probiotics. Many species have 
been described to control inflammation, and in many cases the induction of Treg may be 
central to this function [96]. A well-studied example is the VSL#3 cocktail of probiotics, 
which causes increased IL-10 production and a population of TGFβ-producing cells that 
prevent colitis in recipient mice upon transfer in a TGFβ-dependent manner [202]. 
Another is Bifidobacteria infantis, which led to an increase in CD4+CD25+ Treg and a 
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reduction in inflammation during infection with Salmonella typhimurium, and this 
protection could also be transferred with the Treg population. In some cases, bacteria that 
act as probiotics may produce a molecule that induce protective intestinal immune 
responses, such as polysaccharide A (PSA) produced by Bacteroides fragilis [203, 204]. 
Administration of purified PSA alone can protect against the induction of experimental 
IBD, and this is dependent upon the ability of T cells to produce IL-10, suggesting that 
this factor can cause the production or expansion of IL-10-producing regulatory cells of 
either the Tr1 or Foxp3+ subsets. These probiotics have the advantage of being able to 
target directly an region and a subset of T cells which is directly relevant to disease in a 
way that is much more efficient than our current methods allow us to do in vitro. 
Additionally, it is non-invasive and very safe. These organisms and their immune effects 
warrant further study and hold promise in the safe effective treatment of intestinal 
inflammation. 
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